Activation	O
of	O
early	B-DNA
growth	I-DNA
response	I-DNA
1	I-DNA
gene	I-DNA
transcription	O
and	O
pp90rsk	B-protein
during	O
induction	O
of	O
monocytic	O
differentiation	O
.	O

The	O
present	O
work	O
has	O
studied	O
mechanisms	O
responsible	O
for	O
induction	O
of	O
early	B-DNA
growth	I-DNA
response	I-DNA
1	I-DNA
(	I-DNA
EGR-1	I-DNA
)	I-DNA
gene	I-DNA
expression	O
during	O
monocytic	O
differentiation	O
of	O
U-937	B-cell_line
myeloid	I-cell_line
leukemia	I-cell_line
cells	I-cell_line
.	O

Differentiation	O
of	O
U-937	B-cell_line
cells	I-cell_line
with	O
12-O-tetradecanoylphorbol-13-acetate	O
(	O
TPA	O
)	O
,	O
an	O
activator	O
of	O
the	O
serine/threonine	B-protein
protein	I-protein
kinase	I-protein
C	I-protein
,	O
was	O
associated	O
with	O
transcriptional	O
activation	O
of	O
EGR-1	B-DNA
promoter-reporter	I-DNA
constructs	I-DNA
.	O

The	O
EGR-1	B-DNA
promoter	I-DNA
contains	O
six	O
CC	O
(	O
A/T	O
)	O
6GG	O
(	O
CArG	O
)	O
motifs	O
.	O

The	O
two	O
5'-most	B-DNA
distal	I-DNA
CArG	I-DNA
sequences	I-DNA
conferred	O
TPA	O
inducibility	O
.	O

In	O
contrast	O
,	O
there	O
was	O
little	O
effect	O
of	O
TPA	O
on	O
EGR-1	B-DNA
transcription	O
in	O
a	O
TPA-resistant	B-cell_line
U-937	I-cell_line
cell	I-cell_line
variant	I-cell_line
,	O
designated	O
TUR	B-cell_line
.	O

Treatment	O
of	O
both	O
U-937	B-cell_line
and	O
TUR	B-cell_line
cells	I-cell_line
with	O
okadaic	O
acid	O
,	O
an	O
inhibitor	O
of	O
serine/threonine	B-protein
protein	I-protein
phosphatases	I-protein
1	I-protein
and	I-protein
2A	I-protein
,	O
was	O
associated	O
with	O
induction	O
of	O
monocytic	O
differentiation	O
and	O
EGR-1	B-DNA
transcription	O
through	O
the	O
5'-most	B-DNA
CArG	I-DNA
element	I-DNA
.	O

Since	O
these	O
findings	O
supported	O
the	O
involvement	O
of	O
serine/threonine	O
protein	O
phosphorylation	O
in	O
the	O
regulation	O
of	O
EGR-1	B-DNA
expression	O
,	O
we	O
studied	O
activation	O
of	O
the	O
40S	B-protein
ribosomal	I-protein
protein	I-protein
S6	I-protein
serine/threonine	I-protein
kinases	I-protein
,	O
pp70S6K	B-protein
and	O
pp90rsk	B-protein
.	O

Although	O
both	O
kinases	O
participate	O
in	O
regulating	O
cell	O
growth	O
,	O
there	O
was	O
no	O
detectable	O
activation	O
of	O
pp70S6K	B-protein
during	O
TPA-	O
or	O
okadaic	O
acid-induced	O
monocytic	O
differentiation	O
.	O

Moreover	O
,	O
rapamycin	O
,	O
an	O
inhibitor	O
of	O
pp70S6K	B-protein
activation	O
,	O
had	O
no	O
effect	O
on	O
induction	O
of	O
EGR-1	B-DNA
expression	O
.	O

In	O
contrast	O
,	O
analysis	O
of	O
pp90rsk	B-protein
activity	O
by	O
phosphorylation	O
of	O
a	O
peptide	O
derived	O
from	O
S6	B-protein
protein	I-protein
demonstrated	O
stimulation	O
of	O
this	O
kinase	B-protein
in	O
TPA-treated	B-cell_line
U-937	I-cell_line
,	I-cell_line
and	I-cell_line
not	I-cell_line
TUR	I-cell_line
,	I-cell_line
cells	I-cell_line
.	O

Okadaic	O
acid	O
treatment	O
of	O
both	O
cell	O
types	O
was	O
associated	O
with	O
activation	O
of	O
pp90rsk	B-protein
.	O

Vol	NULL
.	NULL

5	NULL
,	NULL
259-265	NULL
,	NULL
March	NULL
1994	NULL
Cell	NULL
Growth	NULL
&	NULL
Differentiation	NULL
Activation	NULL
of	NULL
Early	NULL
Growth	NULL
Response	NULL
1	NULL
Gene	NULL
Transcription	NULL
and	NULL
pp90	NULL
``	NULL
*	NULL
during	NULL
Induction	NULL
of	NULL
Monocytic	NULL
Differentiation	NULL
Surender	NULL
Kharbanda	NULL
,	NULL
``	NULL
A.	NULL
Saleem	NULL
,	NULL
Masanori	NULL
Hirano	NULL
,	NULL
Yutaka	NULL
Emoto	NULL
,	NULL
Vikas	NULL
Sukhatme	NULL
,	NULL
John	NULL
Blenis	NULL
,	NULL
and	NULL
Donald	NULL
Kufe	NULL
Division	NULL
of	NULL
Cancer	NULL
Pharmacology	NULL
,	NULL
Dana-Farber	NULL
Cancer	NULL
Institute	NULL
,	NULL
Boston	NULL
,	NULL
Massachusetts	NULL
02115	NULL
[	NULL
S.	NULL
K.	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
M.	NULL
H.	NULL
,	NULL
Y.	NULL
E.	NULL
,	NULL
D.	NULL
K.	NULL
}	NULL
;	NULL
Division	NULL
of	NULL
Nephrology	NULL
,	NULL
Beth	NULL
Israel	NULL
Hospital	NULL
,	NULL
Boston	NULL
,	NULL
Massachusetts	NULL
02215	NULL
[	NULL
V.	NULL
S.	NULL
]	NULL
;	NULL
and	NULL
Department	NULL
of	NULL
Cellular	NULL
and	NULL
Molecular	NULL
Physiology	NULL
,	NULL
Harvard	NULL
Medical	NULL
School	NULL
,	NULL
Boston	NULL
,	NULL
Massachusetts	NULL
02115	NULL
[	NULL
J	NULL
.	NULL

B	NULL
.	NULL
]	NULL

Abstract	NULL
The	NULL
present	NULL
work	NULL
has	NULL
studied	NULL
mechanisms	NULL
responsible	NULL
for	NULL
induction	NULL
of	NULL
early	NULL
growth	NULL
response	NULL
1	NULL
(	NULL
FEGR-1	NULL
)	NULL
gene	NULL
expression	NULL
during	NULL
monocytic	NULL
differentiation	NULL
of	NULL
U-937	NULL
myeloid	NULL
leukemia	NULL
cells	NULL
.	NULL

Differentiation	NULL
of	NULL
U-937	NULL
cells	NULL
with	NULL
12-O-tetradecanoyliphorbol-13-acetate	NULL
(	NULL
TPA	NULL
)	NULL
,	NULL
an	NULL
activator	NULL
of	NULL
the	NULL
serine/threonine	NULL
protein	NULL
kinase	NULL
C	NULL
,	NULL
was	NULL
associated	NULL
with	NULL
transcriptional	NULL
activation	NULL
of	NULL
EGR-1	NULL
promoter-reporter	NULL
constructs	NULL
.	NULL

The	NULL
EGR-1	NULL
promoter	NULL
contains	NULL
six	NULL
(	NULL
CArG	NULL
)	NULL
motifs	NULL
.	NULL

The	NULL
two	NULL
5'-most	NULL
distal	NULL
CArG	NULL
sequences	NULL
conferred	NULL
TPA	NULL
inducibility	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
there	NULL
was	NULL
little	NULL
effect	NULL
of	NULL
TPA	NULL
on	NULL
EGR-1	NULL
transcription	NULL
in	NULL
a	NULL
TPA-resistant	NULL
U-937	NULL
cell	NULL
variant	NULL
,	NULL
designated	NULL
TUR	NULL
.	NULL

Treatment	NULL
of	NULL
both	NULL
U-937	NULL
and	NULL
TUR	NULL
cells	NULL
with	NULL
okadaic	NULL
acid	NULL
,	NULL
an	NULL
inhibitor	NULL
of	NULL
serine/	NULL
threonine	NULL
protein	NULL
phosphatases	NULL
1	NULL
and	NULL
2A	NULL
,	NULL
was	NULL
associated	NULL
with	NULL
induction	NULL
of	NULL
monocytic	NULL
differentiation	NULL
and	NULL
EGR-1	NULL
transcription	NULL
through	NULL
the	NULL
5'-most	NULL
CArG	NULL
element	NULL
.	NULL

Since	NULL
these	NULL
findings	NULL
supported	NULL
the	NULL
involvement	NULL
of	NULL
serine/threonine	NULL
protein	NULL
phosphorylation	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
EGR-1	NULL
expression	NULL
,	NULL
we	NULL
studied	NULL
activation	NULL
of	NULL
the	NULL
405	NULL
ribosomal	NULL
protein	NULL
S6	NULL
serine/threonine	NULL
kinases	NULL
,	NULL
and	NULL
pp90	NULL
``	NULL
*	NULL
.	NULL

Although	NULL
both	NULL
kinases	NULL
participate	NULL
in	NULL
regulating	NULL
cell	NULL
growth	NULL
,	NULL
there	NULL
was	NULL
no	NULL
detectable	NULL
activation	NULL
of	NULL
during	NULL
TPA-	NULL
or	NULL
okadaic	NULL
acid-induced	NULL
monocytic	NULL
differentiation	NULL
.	NULL

Moreover	NULL
,	NULL
rapamycin	NULL
,	NULL
an	NULL
inhibitor	NULL
of	NULL
pp70°**	NULL
activation	NULL
,	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
induction	NULL
of	NULL
EGR-1	NULL
expression	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
analysis	NULL
of	NULL
pp90	NULL
``	NULL
**	NULL
activity	NULL
by	NULL
phosphorylation	NULL
of	NULL
a	NULL
peptide	NULL
derived	NULL
from	NULL
$	NULL
6	NULL
protein	NULL
demonstrated	NULL
stimulation	NULL
of	NULL
this	NULL
kinase	NULL
in	NULL
TPA-treated	NULL
U-937	NULL
,	NULL
and	NULL
not	NULL
TUR	NULL
,	NULL
cells	NULL
.	NULL

Okadaic	NULL
acid	NULL
treatment	NULL
of	NULL
both	NULL
cell	NULL
types	NULL
was	NULL
associated	NULL
with	NULL
activation	NULL
of	NULL
pp90	NULL
``	NULL
**	NULL
.	NULL

Since	NULL
serum	NULL
response	NULL
factor	NULL
interacts	NULL
with	NULL
CArG	NULL
elements	NULL
and	NULL
is	NULL
directly	NULL
phosphorylated	NULL
by	NULL
pp90	NULL
``	NULL
*	NULL
,	NULL
the	NULL
present	NULL
findings	NULL
suggest	NULL
that	NULL
activation	NULL
of	NULL
the	NULL
pp90	NULL
``	NULL
**	NULL
cascade	NULL
may	NULL
contribute	NULL
to	NULL
induction	NULL
of	NULL
EGR-1	NULL
transcription	NULL
and	NULL
appearance	NULL
of	NULL
the	NULL
differentiated	NULL
monocytic	NULL
phenotype	NULL
.	NULL

Received	NULL
9/23/93	NULL
;	NULL
revised	NULL
11/17/93	NULL
;	NULL
accepted	NULL
12/15/93	NULL
.	NULL
'	NULL

This	NULL
investigation	NULL
was	NULL
supported	NULL
by	NULL
USPHS	NULL
Grant	NULL
CA42802	NULL
awarded	NULL
by	NULL
the	NULL
National	NULL
Cancer	NULL
Institute	NULL
,	NULL
Department	NULL
of	NULL
Health	NULL
and	NULL
Human	NULL
Services	NULL
.	NULL

2	NULL
To	NULL
whom	NULL
requests	NULL
for	NULL
reprints	NULL
should	NULL
be	NULL
addressed	NULL
,	NULL
at	NULL
Division	NULL
of	NULL
Cancer	NULL
Pharmacology	NULL
,	NULL
Dana-Farber	NULL
Cancer	NULL
Institute	NULL
,	NULL
Harvard	NULL
Medical	NULL
School	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
02115	NULL
.	NULL

Introduction	NULL
Previous	NULL
work	NULL
has	NULL
demonstrated	NULL
that	NULL
treatment	NULL
of	NULL
human	NULL
myeloid	NULL
leukemia	NULL
cell	NULL
lines	NULL
with	NULL
TPA	NULL
is	NULL
associated	NULL
with	NULL
induction	NULL
of	NULL
differentiation	NULL
along	NULL
the	NULL
monocytic	NULL
lineage	NULL
(	NULL
1-3	NULL
)	NULL
.	NULL

TPA	NULL
activates	NULL
the	NULL
serine/threonine-specific	NULL
PKC	NULL
(	NULL
4	NULL
)	NULL
,	NULL
and	NULL
thus	NULL
certain	NULL
insights	NULL
are	NULL
available	NULL
regarding	NULL
early	NULL
signals	NULL
in	NULL
this	NULL
process	NULL
.	NULL

Other	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
TPA-induced	NULL
differentiation	NULL
of	NULL
U-937	NULL
leukemia	NULL
cells	NULL
is	NULL
accompanied	NULL
by	NULL
increased	NULL
expression	NULL
of	NULL
the	NULL
early	NULL
growth	NULL
response	NULL
1	NULL
(	NULL
EGR-1	NULL
,	NULL
zif/268	NULL
,	NULL
NGF-IA	NULL
,	NULL
Krox24	NULL
,	NULL
TIS-8	NULL
)	NULL
gene	NULL
(	NULL
5-10	NULL
)	NULL
.	NULL

The	NULL
finding	NULL
that	NULL
this	NULL
gene	NULL
is	NULL
activated	NULL
by	NULL
other	NULL
agents	NULL
which	NULL
induce	NULL
monocytic	NULL
differentiation	NULL
of	NULL
both	NULL
leukemic	NULL
cells	NULL
and	NULL
normal	NULL
monocytes	NULL
suggested	NULL
that	NULL
EGR-1	NULL
may	NULL
function	NULL
in	NULL
transducing	NULL
early	NULL
nuclear	NULL
signals	NULL
into	NULL
longer	NULL
term	NULL
changes	NULL
in	NULL
gene	NULL
expression	NULL
associated	NULL
with	NULL
the	NULL
monocytic	NULL
phenotype	NULL
(	NULL
11-13	NULL
)	NULL
.	NULL

Indeed	NULL
,	NULL
recent	NULL
studies	NULL
have	NULL
suggested	NULL
that	NULL
EGR-1	NULL
is	NULL
required	NULL
for	NULL
differentiation	NULL
along	NULL
the	NULL
monocytic	NULL
lineage	NULL
(	NULL
14	NULL
)	NULL
.	NULL

EGR-1	NULL
expression	NULL
,	NULL
however	NULL
,	NULL
is	NULL
not	NULL
restricted	NULL
to	NULL
myeloid	NULL
cells	NULL
.	NULL

Neuronal	NULL
differentiation	NULL
of	NULL
PC12	NULL
rat	NULL
pheo-chromocytoma	NULL
cells	NULL
by	NULL
nerve	NULL
growth	NULL
factor	NULL
and	NULL
cardiac	NULL
differentiation	NULL
of	NULL
the	NULL
pluripotent	NULL
embryonal	NULL
carcinoma	NULL
P1951801¥1	NULL
line	NULL
are	NULL
associated	NULL
with	NULL
increases	NULL
in	NULL
EGR-1	NULL
transcripts	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
EGR-1	NULL
gene	NULL
is	NULL
induced	NULL
during	NULL
mitogenic	NULL
stimulation	NULL
of	NULL
diverse	NULL
cell	NULL
types	NULL
,	NULL
including	NULL
fibro-blasts	NULL
,	NULL
epithelial	NULL
cells	NULL
,	NULL
and	NULL
lymphocytes	NULL
(	NULL
15	NULL
,	NULL
16	NULL
)	NULL
.	NULL

Although	NULL
these	NULL
findings	NULL
have	NULL
indicated	NULL
that	NULL
EGR-1	NULL
is	NULL
involved	NULL
in	NULL
both	NULL
growth	NULL
and	NULL
differentiation	NULL
,	NULL
few	NULL
insights	NULL
are	NULL
available	NULL
regarding	NULL
the	NULL
signaling	NULL
mechanisms	NULL
responsible	NULL
for	NULL
induction	NULL
of	NULL
this	NULL
gene	NULL
.	NULL

Recent	NULL
attention	NULL
has	NULL
been	NULL
directed	NULL
toward	NULL
defining	NULL
cytoplasmic	NULL
and	NULL
nuclear	NULL
signaling	NULL
pathways	NULL
that	NULL
contribute	NULL
to	NULL
the	NULL
regulation	NULL
of	NULL
immediate-early	NULL
genes	NULL
.	NULL

This	NULL
effort	NULL
has	NULL
in	NULL
part	NULL
been	NULL
focused	NULL
on	NULL
MAP	NULL
kinases	NULL
.	NULL

Several	NULL
serine/threonine	NULL
protein	NULL
kinases	NULL
have	NULL
been	NULL
implicated	NULL
in	NULL
the	NULL
control	NULL
of	NULL
early	NULL
response	NULL
gene	NULL
expression	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
their	NULL
spatial	NULL
distribution	NULL
and	NULL
temporal	NULL
regulation	NULL
.	NULL

These	NULL
include	NULL
the	NULL
405	NULL
ribosomal	NULL
protein	NULL
S6	NULL
kinases	NULL
,	NULL
designated	NULL
pp90	NULL
``	NULL
¢	NULL
and	NULL
pp70°°*	NULL
(	NULL
17-20	NULL
)	NULL
.	NULL

Activation	NULL
of	NULL
both	NULL
pp90	NULL
``	NULL
®	NULL
and	NULL
pp70°	NULL
``	NULL
*	NULL
involves	NULL
serine/threonine	NULL
phosphorylation	NULL
but	NULL
occurs	NULL
through	NULL
distinct	NULL
signaling	NULL
pathways	NULL
(	NULL
18	NULL
,	NULL
20-22	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
kinases	NULL
responsible	NULL
for	NULL
activation	NULL
of	NULL
pp70°*	NULL
``	NULL
remain	NULL
un-known	NULL
,	NULL
the	NULL
MAP	NULL
kinases	NULL
appear	NULL
to	NULL
regulate	NULL
pp90	NULL
``	NULL
*	NULL
``	NULL
activity	NULL
(	NULL
23	NULL
,	NULL
24	NULL
)	NULL
.	NULL

Activated	NULL
MAP	NULL
kinases	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
phosphorylate	NULL
transcription	NULL
factors	NULL
such	NULL
as	NULL
Jun	NULL
and	NULL
Fos	NULL
in	NULL
vitro	NULL
(	NULL
25	NULL
,	NULL
26	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
regulation	NULL
of	NULL
nuclear	NULL
MAP	NULL
kinase	NULL
and	NULL
pp90	NULL
``	NULL
®*	NULL
activities	NULL
by	NULL
growth	NULL
factors	NULL
is	NULL
coordinated	NULL
with	NULL
induction	NULL
of	NULL
certain	NULL
early	NULL
response	NULL
genes	NULL
(	NULL
27	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
have	NULL
suggested	NULL
that	NULL
MAP	NULL
kinases	NULL
and	NULL
>	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
TPA	NULL
,	NULL
12-O-tetradecanoylphorbol-1	NULL
3-acetate	NULL
;	NULL
PKC	NULL
,	NULL
protein	NULL
kinase	NULL
C	NULL
;	NULL
EGR	NULL
,	NULL
early	NULL
growth	NULL
response	NULL
;	NULL
MAP	NULL
,	NULL
mitogen-activated	NULL
protein	NULL
;	NULL
CArG	NULL
,	NULL
CC	NULL
(	NULL
A/T	NULL
)	NULL
;	NULL
GG	NULL
;	NULL
SRF	NULL
,	NULL
serum	NULL
response	NULL
factor	NULL
;	NULL
CAT	NULL
,	NULL
chloramphenicol	NULL
acetyltransferase	NULL
;	NULL
SRE	NULL
,	NULL
serum	NULL
response	NULL
element	NULL
;	NULL
PBS	NULL
,	NULL
phosphate-buffered	NULL
saline	NULL
;	NULL
kd	NULL
,	NULL
kilodalton	NULL
(	NULL
s	NULL
)	NULL
;	NULL
kb	NULL
,	NULL
kilobase	NULL
(	NULL
s	NULL
)	NULL
;	NULL
SDS	NULL
,	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
.	NULL

260	NULL
Induction	NULL
of	NULL
EGR-1	NULL
Gene	NULL
Transcription	NULL
TPA	NULL
OA	NULL
A.	NULL
on	NULL
s	NULL
@	NULL
»	NULL
To	NULL
ttt	NULL
--	NULL
-	NULL
I	NULL
®	NULL
£	NULL
£	NULL
£	NULL
£	NULL
£	NULL
O	NULL
g	NULL
£	NULL
£	NULL
£	NULL
£	NULL
I	NULL
-	NULL
-m	NULL
o	NULL
ag	NULL
1	NULL
-	NULL
®	NULL
©	NULL
ao	NULL
gs	NULL
3	NULL
m	NULL
-	NULL
o	NULL
-J	NULL
r	NULL
--	NULL
W	NULL
28S-	NULL
I	NULL
:	NULL
x	NULL
-28S	NULL
-=	NULL
«	NULL
tk	NULL
¥	NULL
a	NULL
E	NULL
G	NULL
R	NULL
1	NULL
Fo	NULL
d	NULL
f	NULL
EGR-1	NULL
-	NULL
_	NULL
ig	NULL
.	NULL

1	NULL
.	NULL

-	NULL
Induction	NULL
of	NULL
-1	NULL
expres-18	NULL
S	NULL
¥	NULL
1	NULL
88	NULL
sion	NULL
by	NULL
okadaic	NULL
acid	NULL
and	NULL
TPA	NULL
.	NULL

k	NULL
U-937	NULL
(	NULL
A	NULL
)	NULL
and	NULL
TUR	NULL
(	NULL
B	NULL
)	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
32	NULL
nm	NULL
TPA	NULL
or	NULL
40	NULL
ng/ml	NULL
okadaic	NULL
acid	NULL
(	NULL
0A	NULL
)	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
.	NULL

Total	NULL
cellular	NULL
RNA	NULL
(	NULL
20	NULL
pg	NULL
)	NULL
was	NULL
hybridized	NULL
to	NULL
the	NULL
+*P-labeled	NULL
EGR-1	NULL
probe	NULL
.	NULL

Hybridization	NULL
to	NULL
the	NULL
actin	NULL
B	NULL
TPA	NULL
OA	NULL
probe	NULL
demonstrated	NULL
equal	NULL
loading	NULL
®	NULL
r	NULL
--	NULL
ooo	NULL
of	NULL
the	NULL
lanes	NULL
.	NULL

€	NULL
<	NULL
<	NULL
<	NULL
E	NULL
ze	NULL
<	NULL
<	NULL
£	NULL
<	NULL
hadley	NULL
)	NULL
a	NULL
-o	NULL
2	NULL
-	NULL
®	NULL
©	NULL
ao	NULL
-~	NULL
AN	NULL
k-	NULL
~~	NULL
N	NULL
28S	NULL
-188-	NULL
_	NULL
I	NULL
f	NULL
TuR	NULL
ﬂ	NULL
”	NULL
%	NULL
g	NULL
13.	NULL
are	NULL
involved	NULL
in	NULL
transducing	NULL
growth-regulatory	NULL
signals	NULL
from	NULL
the	NULL
cell	NULL
membrane	NULL
to	NULL
the	NULL
nucleus	NULL
.	NULL

The	NULL
potential	NULL
role	NULL
of	NULL
this	NULL
signaling	NULL
pathway	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
cellular	NULL
differentiation	NULL
,	NULL
however	NULL
,	NULL
is	NULL
unclear	NULL
.	NULL

The	NULL
present	NULL
studies	NULL
demonstrate	NULL
that	NULL
activation	NULL
of	NULL
the	NULL
EGR-1	NULL
gene	NULL
during	NULL
TPA-induced	NULL
monocytic	NULL
differentiation	NULL
is	NULL
mediated	NULL
through	NULL
serum	NULL
response	NULL
or	NULL
CArG	NULL
elements	NULL
.	NULL

Previous	NULL
work	NULL
has	NULL
demonstrated	NULL
that	NULL
pp90	NULL
``	NULL
®	NULL
``	NULL
directly	NULL
phosphorylates	NULL
SRF	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Since	NULL
this	NULL
phosphorylation	NULL
of	NULL
SRF	NULL
enhances	NULL
the	NULL
affinity	NULL
and	NULL
rate	NULL
with	NULL
which	NULL
it	NULL
interacts	NULL
with	NULL
the	NULL
CArG	NULL
box	NULL
(	NULL
28	NULL
)	NULL
,	NULL
we	NULL
asked	NULL
whether	NULL
pp90	NULL
``	NULL
®®	NULL
is	NULL
activated	NULL
during	NULL
monocytic	NULL
differentiation	NULL
.	NULL

Using	NULL
both	NULL
TPA	NULL
and	NULL
okadaic	NULL
acid	NULL
,	NULL
an	NULL
inhibitor	NULL
of	NULL
serine/threonine	NULL
protein	NULL
phosphatases	NULL
PP-1	NULL
and	NULL
PP-2A	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
activation	NULL
of	NULL
nuclear	NULL
pp90**	NULL
is	NULL
associated	NULL
with	NULL
induction	NULL
of	NULL
EGR-1	NULL
and	NULL
the	NULL
differentiated	NULL
monocytic	NULL
phenotype	NULL
.	NULL

Results	NULL
Previous	NULL
work	NULL
has	NULL
demonstrated	NULL
that	NULL
treatment	NULL
of	NULL
human	NULL
myeloid	NULL
leukemia	NULL
celts	NULL
is	NULL
associated	NULL
with	NULL
increased	NULL
EGR-1	NULL
mRNA	NULL
levels	NULL
(	NULL
6	NULL
)	NULL
.	NULL

Similar	NULL
findings	NULL
were	NULL
obtained	NULL
in	NULL
the	NULL
present	NULL
studies	NULL
with	NULL
U-937	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
3.4-kb	NULL
EGR-1	NULL
transcripts	NULL
were	NULL
at	NULL
low	NULL
to	NULL
undetectable	NULL
levels	NULL
in	NULL
untreated	NULL
U-937	NULL
cells	NULL
,	NULL
exposure	NULL
to	NULL
32	NULL
nm	NULL
TPA	NULL
resulted	NULL
in	NULL
increased	NULL
EGR-1	NULL
expression	NULL
,	NULL
which	NULL
was	NULL
detectable	NULL
at	NULL
1	NULL
h	NULL
and	NULL
maximal	NULL
at	NULL
3-6	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

Exposure	NULL
of	NULL
U-937	NULL
cells	NULL
to	NULL
40	NULL
ng/ml	NULL
okadaic	NULL
acid	NULL
was	NULL
also	NULL
associated	NULL
with	NULL
a	NULL
transient	NULL
induction	NULL
of	NULL
EGR-1	NULL
expression	NULL
,	NULL
which	NULL
was	NULL
maximal	NULL
at	NULL
3-6	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
were	NULL
compared	NULL
with	NULL
the	NULL
effects	NULL
of	NULL
TPA	NULL
and	NULL
okadaic	NULL
acid	NULL
on	NULL
a	NULL
U-937	NULL
cell	NULL
variant	NULL
,	NULL
designated	NULL
TUR	NULL
,	NULL
which	NULL
was	NULL
selected	NULL
for	NULL
resistance	NULL
to	NULL
TPA-induced	NULL
growth	NULL
inhibition	NULL
and	NULL
other	NULL
characteristics	NULL
,	NULL
such	NULL
as	NULL
adherence	NULL
,	NULL
of	NULL
the	NULL
differentiated	NULL
monocytic	NULL
phenotype	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
effects	NULL
of	NULL
TPA	NULL
on	NULL
U-937	NULL
cells	NULL
,	NULL
induction	NULL
of	NULL
EGR-1	NULL
expression	NULL
was	NULL
attenuated	NULL
during	NULL
TPA	NULL
treatment	NULL
of	NULL
the	NULL
TUR	NULL
clone	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
B	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
finding	NULL
that	NULL
TUR	NULL
cells	NULL
respond	NULL
to	NULL
okadaic	NULL
acid	NULL
with	NULL
increases	NULL
in	NULL
EGR-1	NULL
mRNA	NULL
levels	NULL
indicated	NULL
that	NULL
certain	NULL
signaling	NULL
pathways	NULL
associated	NULL
with	NULL
induction	NULL
of	NULL
this	NULL
gene	NULL
are	NULL
intact	NULL
in	NULL
the	NULL
variant	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

In	NULL
order	NULL
to	NULL
determine	NULL
the	NULL
mechanisms	NULL
responsible	NULL
for	NULL
TPA-induced	NULL
EGR-1	NULL
mRNA	NULL
levels	NULL
,	NULL
we	NULL
used	NULL
a	NULL
construct	NULL
containing	NULL
the	NULL
EGR-1	NULL
promoter	NULL
region	NULL
(	NULL
positions	NULL
-957	NULL
to	NULL
+248	NULL
)	NULL
ligated	NULL
to	NULL
the	NULL
CAT	NULL
reporter	NULL
gene	NULL
(	NULL
pEGR-1P1.2	NULL
)	NULL
.	NULL

This	NULL
region	NULL
includes	NULL
several	NULL
potential	NULL
regulatory	NULL
elements	NULL
with	NULL
two	NULL
Jun/	NULL
AP-1	NULL
binding	NULL
sites	NULL
and	NULL
six	NULL
CArG	NULL
boxes	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
.	NULL

Exposure	NULL
of	NULL
pEGR-1P1.2-transfected	NULL
U-937	NULL
cells	NULL
to	NULL
TPA	NULL
was	NULL
associated	NULL
with	NULL
a	NULL
4.5	NULL
*	NULL
1.7-fold	NULL
(	NULL
mean	NULL
+	NULL
SD	NULL
of	NULL
three	NULL
determinations	NULL
)	NULL
increase	NULL
in	NULL
CAT	NULL
activity	NULL
compared	NULL
with	NULL
transfected	NULL
cells	NULL
not	NULL
exposed	NULL
to	NULL
this	NULL
agent	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
there	NULL
was	NULL
no	NULL
detectable	NULL
induction	NULL
of	NULL
the	NULL
minimal	NULL
pE7Z0-CAT	NULL
construct	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

Similar	NULL
studies	NULL
were	NULL
performed	NULL
with	NULL
pE425	NULL
(	NULL
positions	NULL
-425	NULL
to	NULL
+65	NULL
;	NULL
six	NULL
CArG	NULL
boxes	NULL
without	NULL
the	NULL
two	NULL
AP-1	NULL
sites	NULL
)	NULL
.	NULL

pF425	NULL
was	NULL
somewhat	NULL
more	NULL
responsive	NULL
to	NULL
TPA	NULL
than	NULL
pEGR-1P1.2	NULL
,	NULL
with	NULL
a	NULL
7.2	NULL
*	NULL
2.1	NULL
-fold	NULL
(	NULL
mean	NULL
*	NULL
SD	NULL
of	NULL
three	NULL
determinations	NULL
)	NULL
increase	NULL
in	NULL
TPA-induced	NULL
CAT	NULL
activity	NULL
compared	NULL
with	NULL
that	NULL
obtained	NULL
with	NULL
pE425	NULL
transfected	NULL
,	NULL
but	NULL
un-treated	NULL
,	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

Transfection	NULL
of	NULL
pE395	NULL
,	NULL
which	NULL
contains	NULL
the	NULL
five	NULL
proximal	NULL
CArG	NULL
boxes	NULL
,	NULL
also	NULL
conferred	NULL
TPA	NULL
inducibility	NULL
,	NULL
whereas	NULL
deletion	NULL
of	NULL
the	NULL
next	NULL
CArG	NULL
box	NULL
(	NULL
pE359	NULL
)	NULL
resulted	NULL
in	NULL
little	NULL
if	NULL
any	NULL
TPA-induced	NULL
CAT	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
indicated	NULL
that	NULL
the	NULL
region	NULL
encompassing	NULL
the	NULL
first	NULL
two	NULL
CArG	NULL
elements	NULL
mediates	NULL
TPA-induced	NULL
expression	NULL
of	NULL
the	NULL
EGR-1	NULL
gene	NULL
.	NULL

Similar	NULL
transient	NULL
expression	NULL
studies	NULL
were	NULL
performed	NULL
with	NULL
TUR	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
there	NULL
was	NULL
no	NULL
detectable	NULL
inducibility	NULL
of	NULL
the	NULL
EGR-1	NULL
promoter-CAT	NULL
constructs	NULL
during	NULL
TPA	NULL
treatment	NULL
of	NULL
these	NULL
cells	NULL
.	NULL

For	NULL
example	NULL
,	NULL
percentage	NULL
conversion	NULL
with	NULL
pE425	NULL
was	NULL
0.16	NULL
and	NULL
0.19	NULL
in	NULL
control	NULL
and	NULL
TPA-induced	NULL
TUR	NULL
cells	NULL
,	NULL
respectively	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
these	NULL
cells	NULL
responded	NULL
to	NULL
okadaic	NULL
acid	NULL
with	NULL
activation	NULL
of	NULL
EGR-1	NULL
transcription	NULL
.	NULL

Transfection	NULL
of	NULL
the	NULL
pE425	NULL
construct	NULL
demonstrated	NULL
okadaic	NULL
acid	NULL
responsiveness	NULL
with	NULL
a	NULL
4.4	NULL
+	NULL
1.1-fold	NULL
increase	NULL
in	NULL
CAT	NULL
activity	NULL
,	NULL
whereas	NULL
little	NULL
inducibility	NULL
by	NULL
okadaic	NULL
acid	NULL
was	NULL
observed	NULL
with	NULL
both	NULL
pE395	NULL
and	NULL
pE359	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Other	NULL
studies	NULL
with	NULL
U-937	NULL
cells	NULL
Cell	NULL
Growth	NULL
&	NULL
Differentiation	NULL
A	NULL
.	NULL

1000	NULL
-750	NULL
-500	NULL
250	NULL
0	NULL
+248	NULL
E	NULL
|	NULL
|	NULL
L	NULL
14	NULL
’	NULL
IH	NULL
-957	NULL
+1	NULL
peanpi2	NULL
_	NULL
-f-	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

TPA-induced	NULL
EGR-1	NULL
transcription	NULL
is	NULL
regulated	NULL
by	NULL
CArG	NULL
elements	NULL
.	NULL

A	NULL
,	NULL
U-937	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
indicated	NULL
constructs	NULL
and	NULL
maintained	NULL
in	NULL
medium	NULL
for	NULL
36	NULL
h.	NULL
TPA	NULL
was	NULL
then	NULL
added	NULL
,	NULL
and	NULL
the	NULL
cells	NULL
were	NULL
harvested	NULL
after	NULL
9	NULL
h	NULL
for	NULL
analysis	NULL
of	NULL
CAT	NULL
activity	NULL
.	NULL

Hatched	NULL
bars	NULL
,	NULL
AP-1	NULL
sites	NULL
;	NULL
solid	NULL
bars	NULL
,	NULL
CArG	NULL
boxes	NULL
.	NULL

B	NULL
,	NULL
conversion	NULL
of	NULL
chloramphenicol	NULL
to	NULL
the	NULL
acetylated	NULL
forms	NULL
is	NULL
shown	NULL
for	NULL
control	NULL
(	NULL
C	NULL
)	NULL
and	NULL
TPA-treated	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
indicated	NULL
constructs	NULL
.	NULL

Percentage	NULL
conversion	NULL
was	NULL
determined	NULL
by	NULL
scintillation	NULL
counting	NULL
.	NULL

The	NULL
relative	NULL
fold	NULL
increase	NULL
(	NULL
mean	NULL
*	NULL
SD	NULL
)	NULL
in	NULL
CAT	NULL
activity	NULL
for	NULL
control	NULL
-	NULL
versus	NULL
TPA-treated	NULL
cells	NULL
was	NULL
calculated	NULL
as	NULL
:	NULL
pEGR-1P1.2	NULL
B	NULL
.	NULL

(	NULL
n	NULL
=	NULL
3	NULL
)	NULL
,	NULL
4.5	NULL
*	NULL
1.7	NULL
;	NULL
pE70	NULL
(	NULL
n	NULL
=	NULL
2	NULL
)	NULL
,	NULL
1.24	NULL
*	NULL
0.16	NULL
;	NULL
pE425	NULL
(	NULL
n	NULL
=	NULL
3	NULL
)	NULL
,	NULL
7.2	NULL
*	NULL
2.1	NULL
;	NULL
pE395	NULL
(	NULL
n	NULL
=	NULL
3	NULL
)	NULL
,	NULL
5.7	NULL
*	NULL
2.1	NULL
;	NULL
pE359	NULL
(	NULL
n	NULL
=	NULL
3	NULL
)	NULL
,	NULL
1.31	NULL
+	NULL
0.22.	NULL
pEGR-1P1.2	NULL
C	NULL
TPA	NULL
%	NULL
Conversion	NULL
0.21	NULL
0.97	NULL
pE425	NULL
pE395	NULL
pE359	NULL
C	NULL
-	NULL
OA	NULL
C	NULL
-	NULL
Oa	NULL
C	NULL
_	NULL
OA	NULL
Pol	NULL
0	NULL
0	NULL
o	NULL
0	NULL
@	NULL
@	NULL
«	NULL
«	NULL
%	NULL
Conversion	NULL
0.72	NULL
3.19	NULL
0.11	NULL
0.15	NULL
0.16	NULL
0.12	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

Okadaic	NULL
acid-induced	NULL
EGR-1	NULL
transcription	NULL
is	NULL
conferred	NULL
by	NULL
the	NULL
most	NULL
CArG	NULL
element	NULL
.	NULL

TUR	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
constructs	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2A	NULL
and	NULL
maintained	NULL
in	NULL
medium	NULL
for	NULL
36	NULL
h.	NULL
Okadaic	NULL
acid	NULL
(	NULL
OA	NULL
)	NULL
was	NULL
then	NULL
added	NULL
,	NULL
and	NULL
the	NULL
cells	NULL
were	NULL
harvested	NULL
after	NULL
9	NULL
h	NULL
for	NULL
analysis	NULL
of	NULL
CAT	NULL
activity	NULL
.	NULL

The	NULL
percentage	NULL
conversion	NULL
of	NULL
chloramphenicol	NULL
to	NULL
the	NULL
acetylated	NULL
forms	NULL
as	NULL
determined	NULL
by	NULL
scintilfation	NULL
counting	NULL
is	NULL
shown	NULL
for	NULL
control	NULL
(	NULL
C	NULL
)	NULL
and	NULL
okadaic	NULL
acid	NULL
(	NULL
OA	NULL
)	NULL
-treated	NULL
cells	NULL
.	NULL

The	NULL
relative	NULL
fold	NULL
increase	NULL
(	NULL
mean	NULL
*	NULL
SD	NULL
)	NULL
in	NULL
CAT	NULL
activity	NULL
for	NULL
control	NULL
versus	NULL
OA-treated	NULL
cells	NULL
was	NULL
calculated	NULL
as	NULL
:	NULL
pE425	NULL
(	NULL
n	NULL
=	NULL
3	NULL
)	NULL
,	NULL
4.4	NULL
*	NULL
1.1	NULL
;	NULL
pE395	NULL
(	NULL
n	NULL
=	NULL
3	NULL
)	NULL
,	NULL
1.4	NULL
*	NULL
0.33	NULL
;	NULL
pE359	NULL
(	NULL
n	NULL
=	NULL
3	NULL
)	NULL
,	NULL
0.76	NULL
*	NULL
0.11.	NULL
have	NULL
demonstrated	NULL
that	NULL
the	NULL
first	NULL
CArG	NULL
element	NULL
linked	NULL
to	NULL
the	NULL
heterologous	NULL
herpes	NULL
simplex	NULL
virus	NULL
thymidine	NULL
kinase	NULL
minimal	NULL
promoter	NULL
and	NULL
CAT	NULL
gene	NULL
is	NULL
able	NULL
to	NULL
confer	NULL
okadaic	NULL
acid	NULL
responsiveness	NULL
,	NULL
whereas	NULL
there	NULL
was	NULL
no	NULL
detectable	NULL
inducibility	NULL
with	NULL
a	NULL
similar	NULL
heterologous	NULL
promoter	NULL
construct	NULL
containing	NULL
a	NULL
mutated	NULL
CC	NULL
(	NULL
A/T	NULL
)	NULL
,	NULL
GG	NULL
sequence	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Similar	NULL
findings	NULL
were	NULL
obtained	NULL
in	NULL
okadaic	NULL
acid-treated	NULL
TUR	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
findings	NULL
indicated	NULL
that	NULL
the	NULL
first	NULL
pE7O	NULL
-	NULL
--	NULL
I-	NULL
CAT	NULL
pesos	NULL
_	NULL
-H	NULL
{	NULL
--	NULL
--	NULL
f	NULL
--	NULL
-|cat	NULL
pesso	NULL
_	NULL
pE425	NULL
pE7O	NULL
pE425	NULL
pE395	NULL
pE359	NULL
C	NULL
TPA	NULL
C	NULL
TPA	NULL
C	NULL
TPA	NULL
C	NULL
TPA	NULL
.	NULL

R	NULL
&	NULL
«	NULL
<	NULL
'	NULL
©	NULL
x	NULL
1	NULL
.	NULL

0.11	NULL
0.14	NULL
0.80	NULL
5.70	NULL
0.16	NULL
1.20	NULL
0.13	NULL
0.17	NULL
CArG	NULL
element	NULL
mediates	NULL
okadaic	NULL
acid-induced	NULL
expression	NULL
of	NULL
the	NULL
EGR-1	NULL
gene	NULL
in	NULL
the	NULL
wild-type	NULL
U-937	NULL
and	NULL
variant	NULL
TUR	NULL
cells	NULL
.	NULL

One	NULL
of	NULL
the	NULL
early	NULL
responses	NULL
to	NULL
mitogen-induced	NULL
cellular	NULL
growth	NULL
is	NULL
the	NULL
phosphorylation	NULL
of	NULL
serine/threonine	NULL
residues	NULL
in	NULL
certain	NULL
translational	NULL
components	NULL
such	NULL
as	NULL
the	NULL
ribosomal	NULL
S6	NULL
protein	NULL
(	NULL
29	NULL
)	NULL
.	NULL

Although	NULL
activation	NULL
of	NULL
pp70°°	NULL
``	NULL
results	NULL
in	NULL
the	NULL
phosphorylation	NULL
of	NULL
S6	NULL
(	NULL
30	NULL
)	NULL
,	NULL
it	NULL
is	NULL
not	NULL
known	NULL
whether	NULL
other	NULL
substrates	NULL
exist	NULL
for	NULL
this	NULL
kinase	NULL
.	NULL

Since	NULL
previous	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
TPA	NULL
activates	NULL
pp70°°	NULL
``	NULL
in	NULL
quiescent	NULL
3T3	NULL
cells	NULL
(	NULL
31	NULL
)	NULL
,	NULL
we	NULL
used	NULL
immunoblot	NULL
analysis	NULL
to	NULL
study	NULL
pp70°°*	NULL
in	NULL
lysates	NULL
from	NULL
U-937	NULL
cells	NULL
.	NULL

The	NULL
results	NULL
demonstrate	NULL
little	NULL
if	NULL
any	NULL
change	NULL
in	NULL
pp70°°®	NULL
levels	NULL
or	NULL
electrophoretic	NULL
mobility	NULL
following	NULL
treatment	NULL
with	NULL
TPA	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

Similar	NULL
findings	NULL
were	NULL
obtained	NULL
during	NULL
exposure	NULL
to	NULL
okadaic	NULL
acid	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

There	NULL
was	NULL
also	NULL
no	NULL
detectable	NULL
change	NULL
in	NULL
pp70°°*	NULL
during	NULL
treatment	NULL
of	NULL
TUR	NULL
cells	NULL
with	NULL
TPA	NULL
or	NULL
okadaic	NULL
acid	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Recent	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
macrolide	NULL
rapamycin	NULL
specifically	NULL
blocks	NULL
signaling	NULL
by	NULL
pp70°°®	NULL
(	NULL
31-33	NULL
)	NULL
.	NULL

Consequently	NULL
,	NULL
we	NULL
asked	NULL
whether	NULL
rapamycin	NULL
inhibits	NULL
events	NULL
associated	NULL
with	NULL
induction	NULL
of	NULL
U-937	NULL
cell	NULL
differentiation	NULL
.	NULL

This	NULL
agent	NULL
had	NULL
no	NULL
detectable	NULL
effect	NULL
on	NULL
TPA-induced	NULL
growth	NULL
arrest	NULL
or	NULL
adherence	NULL
of	NULL
U-937	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
}	NULL
.	NULL

Moreover	NULL
,	NULL
rapamycin	NULL
had	NULL
little	NULL
effect	NULL
on	NULL
TPA-	NULL
or	NULL
okadaic	NULL
acid-induced	NULL
EGR-1	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
and	NULL
the	NULL
absence	NULL
of	NULL
pp70°°®	NULL
activation	NULL
indicated	NULL
that	NULL
pp70°°	NULL
``	NULL
signaling	NULL
is	NULL
not	NULL
essential	NULL
for	NULL
induction	NULL
of	NULL
the	NULL
EGR-1	NULL
gene	NULL
and	NULL
other	NULL
characteristics	NULL
of	NULL
monocytic	NULL
differentiation	NULL
.	NULL

Previous	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
pp70°°~	NULL
and	NULL
pp90	NULL
``	NULL
are	NULL
differentially	NULL
regulated	NULL
by	NULL
a	NULL
variety	NULL
of	NULL
mitogens	NULL
261	NULL
262	NULL
Induction	NULL
of	NULL
EGR-1	NULL
Gene	NULL
Transcription	NULL
GQ—E	NULL
“	NULL
pp70S6K	NULL
<	NULL
-	NULL
-	NULL
&	NULL
B.	NULL
op	NULL
9	NULL
_	NULL
E	NULL
?	NULL

<	NULL
%	NULL
ao	NULL
<	NULL
>	NULL
O	NULL
c	NULL
-	NULL
C	NULL
28S-to	NULL
#	NULL
as	NULL
EGR-1	NULL
18S-	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

-	NULL
Activation	NULL
of	NULL
pp70°°®	NULL
is	NULL
not	NULL
associated	NULL
with	NULL
TPA-	NULL
or	NULL
okadaic	NULL
acid-induced	NULL
monocytic	NULL
differentiation	NULL
.	NULL

A	NULL
,	NULL
U-937	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
TPA	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
.	NULL

Soluble	NULL
proteins	NULL
(	NULL
75	NULL
pig	NULL
)	NULL
were	NULL
subjected	NULL
to	NULL
electrophoresis	NULL
in	NULL
7.5	NULL
%	NULL
SDS-polyacrylamide	NULL
gels	NULL
and	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
paper	NULL
.	NULL

The	NULL
filters	NULL
were	NULL
incubated	NULL
with	NULL
an	NULL
antiserum	NULL
,	NULL
and	NULL
reactivity	NULL
was	NULL
visualized	NULL
by	NULL
chemiluminescence	NULL
.	NULL

Position	NULL
of	NULL
the	NULL
69	NULL
kd	NULL
molecular	NULL
weight	NULL
marker	NULL
is	NULL
shown	NULL
.	NULL

8	NULL
,	NULL
U-937	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
TPA	NULL
or	NULL
okadaic	NULL
acid	NULL
(	NULL
OA	NULL
)	NULL
for	NULL
6	NULL
h.	NULL
Cells	NULL
were	NULL
also	NULL
pretreated	NULL
with	NULL
80	NULL
nm	NULL
rapamycin	NULL
(	NULL
RAP	NULL
)	NULL
for	NULL
3	NULL
h	NULL
and	NULL
then	NULL
exposed	NULL
to	NULL
TPA	NULL
or	NULL
OA	NULL
.	NULL

Total	NULL
cellular	NULL
RNA	NULL
(	NULL
20	NULL
pg	NULL
)	NULL
was	NULL
hybridized	NULL
to	NULL
the	NULL
``	NULL
P-labeled	NULL
EGR-1	NULL
probe	NULL
.	NULL

Hybridization	NULL
to	NULL
the	NULL
actin	NULL
probe	NULL
demonstrated	NULL
equal	NULL
loading	NULL
of	NULL
the	NULL
lanes	NULL
.	NULL

(	NULL
18	NULL
,	NULL
20	NULL
,	NULL
31	NULL
,	NULL
34	NULL
,	NULL
35	NULL
)	NULL
.	NULL

Consequently	NULL
,	NULL
we	NULL
asked	NULL
whether	NULL
TPA-induced	NULL
differentiation	NULL
of	NULL
U-937	NULL
cells	NULL
is	NULL
associated	NULL
with	NULL
activation	NULL
of	NULL
These	NULL
studies	NULL
were	NULL
performed	NULL
by	NULL
purifying	NULL
and	NULL
then	NULL
assaying	NULL
for	NULL
phosphorylation	NULL
of	NULL
S6	NULL
peptide	NULL
.	NULL

Extracts	NULL
of	NULL
U-937	NULL
cells	NULL
treated	NULL
with	NULL
TPA	NULL
were	NULL
partially	NULL
purified	NULL
by	NULL
Q	NULL
Sepharose	NULL
Fast	NULL
Flow	NULL
chromatography	NULL
.	NULL

Increases	NULL
in	NULL
S6	NULL
peptide	NULL
phosphorylation	NULL
were	NULL
detectable	NULL
at	NULL
30	NULL
min	NULL
of	NULL
TPA	NULL
treatment	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
activity	NULL
was	NULL
further	NULL
purified	NULL
by	NULL
absorption	NULL
to	NULL
Mono	NULL
Q	NULL
anion	NULL
exchange	NULL
beads	NULL
and	NULL
then	NULL
elution	NULL
with	NULL
a	NULL
linear	NULL
NaCl	NULL
gradient	NULL
.	NULL

The	NULL
TPA-induced	NULL
pp90®	NULL
activity	NULL
was	NULL
detectable	NULL
in	NULL
a	NULL
peak	NULL
that	NULL
eluted	NULL
with	NULL
0.13	NULL
m	NULL
NaCl	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
there	NULL
was	NULL
little	NULL
if	NULL
any	NULL
S6	NULL
peptide	NULL
phosphorylation	NULL
when	NULL
using	NULL
protein	NULL
purified	NULL
from	NULL
uninduced	NULL
U-937	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

Immunoblot	NULL
analysis	NULL
of	NULL
the	NULL
Mono	NULL
Q	NULL
eluate	NULL
with	NULL
the	NULL
antiserum	NULL
revealed	NULL
a	NULL
major	NULL
species	NULL
at	NULL
approximately	NULL
90	NULL
kilo-daltons	NULL
in	NULL
the	NULL
active	NULL
fractions	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

Similar	NULL
findings	NULL
were	NULL
obtained	NULL
in	NULL
okadaic	NULL
acid-treated	NULL
U-937	NULL
cells	NULL
.	NULL

Treatment	NULL
with	NULL
okadaic	NULL
acid	NULL
was	NULL
associated	NULL
with	NULL
an	NULL
increase	NULL
in	NULL
pp90	NULL
``	NULL
``	NULL
activity	NULL
compared	NULL
to	NULL
that	NULL
in	NULL
control	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
assays	NULL
of	NULL
activation	NULL
in	NULL
TUR	NULL
cells	NULL
revealed	NULL
a	NULL
different	NULL
pattern	NULL
.	NULL

Treatment	NULL
of	NULL
TUR	NULL
cells	NULL
with	NULL
TPA	NULL
had	NULL
no	NULL
detectable	NULL
effect	NULL
on	NULL
pp90	NULL
``	NULL
**	NULL
phosphotransferase	NULL
activity	NULL
,	NULL
whereas	NULL
phosphorylation	NULL
of	NULL
S6	NULL
peptide	NULL
was	NULL
stimulated	NULL
after	NULL
adding	NULL
okadaic	NULL
acid	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
and	NULL
the	NULL
results	NULL
obtained	NULL
with	NULL
U-937	NULL
cells	NULL
indicated	NULL
that	NULL
activation	NULL
is	NULL
associated	NULL
with	NULL
induction	NULL
of	NULL
EGR-1	NULL
expression	NULL
and	NULL
monocytic	NULL
differentiation	NULL
.	NULL

Discussion	NULL
The	NULL
present	NULL
studies	NULL
have	NULL
used	NULL
U-937	NULL
myeloid	NULL
leukemia	NULL
cells	NULL
and	NULL
a	NULL
TPA-resistant	NULL
U-937	NULL
variant	NULL
to	NULL
study	NULL
signaling	NULL
events	NULL
associated	NULL
with	NULL
induction	NULL
of	NULL
monocytic	NULL
differentiation	NULL
.	NULL

The	NULL
5	NULL
0.8	NULL
‘	NULL
ah	NULL
E	NULL
‘	NULL
L	NULL
0.6	NULL
<	NULL
Re	NULL
°	NULL
.4	NULL
=	NULL
2	NULL
nol	NULL
__	NULL
``	NULL
~	NULL
If	NULL
€	NULL
0.24	NULL
{	NULL
+	NULL
--	NULL
~~	NULL
L	NULL
a	NULL
A	NULL
.	NULL

~	NULL
$	NULL
o	NULL
=	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
Fraction	NULL
Number	NULL
B.	NULL
kp	NULL
o	NULL
4	NULL
506	NULL
7	NULL
8	NULL
9	NULL
1011	NULL
116-94-	NULL
*~	NULL
q—prO	NULL
’	NULL
SK	NULL
69	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

-	NULL
Effects	NULL
of	NULL
TPA	NULL
on	NULL
activity	NULL
in	NULL
U-937	NULL
cells	NULL
.	NULL

U-937	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
TPA	NULL
for	NULL
30	NULL
min	NULL
.	NULL

A	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
lysed	NULL
,	NULL
and	NULL
the	NULL
soluble	NULL
fraction	NULL
was	NULL
applied	NULL
to	NULL
a	NULL
Q	NULL
Sepharose	NULL
column	NULL
.	NULL

Protein	NULL
eluting	NULL
at	NULL
0.2	NULL
m	NULL
NaCl	NULL
was	NULL
adjusted	NULL
to	NULL
0.02	NULL
m	NULL
NaCl	NULL
and	NULL
then	NULL
applied	NULL
to	NULL
a	NULL
Mono	NULL
Q	NULL
column	NULL
.	NULL

Fractions	NULL
were	NULL
assayed	NULL
for	NULL
phosphorylation	NULL
of	NULL
S6	NULL
peptide	NULL
after	NULL
elution	NULL
with	NULL
a	NULL
0.0-0.5	NULL
m	NULL
NaCl	NULL
linear	NULL
gradient	NULL
.	NULL

C	NULL
,	NULL
control	NULL
;	NULL
@	NULL
,	NULL
TPA-treated	NULL
.	NULL

B	NULL
,	NULL
fractions	NULL
from	NULL
the	NULL
Mono	NULL
Q	NULL
column	NULL
were	NULL
subjected	NULL
to	NULL
electrophoresis	NULL
in	NULL
7.5	NULL
%	NULL
SDS-polyacrylamide	NULL
gels	NULL
and	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
filters	NULL
.	NULL

The	NULL
filters	NULL
were	NULL
incubated	NULL
with	NULL
an	NULL
anti-pp90	NULL
``	NULL
**	NULL
antiserum	NULL
,	NULL
and	NULL
reactivity	NULL
was	NULL
visualized	NULL
by	NULL
a	NULL
peroxidase	NULL
detection	NULL
system	NULL
.	NULL

wa	NULL
J	NULL
3	NULL
(	NULL
)	NULL
wl	NULL
1oen	NULL
(	NULL
pmol/min	NULL
)	NULL
(	NULL
-	NULL
)	NULL
o	NULL
-	NULL
o	NULL
oe	NULL
s	NULL
S6P	NULL
Phosphorylation	NULL
Fraction	NULL
Number	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

-	NULL
Effects	NULL
of	NULL
okadaic	NULL
acid	NULL
on	NULL
pp90	NULL
``	NULL
**	NULL
activity	NULL
in	NULL
U-937	NULL
cells	NULL
.	NULL

U-937	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
okadaic	NULL
acid	NULL
for	NULL
3	NULL
h.	NULL
Soluble	NULL
proteins	NULL
(	NULL
C	NULL
)	NULL
,	NULL
control	NULL
;	NULL
0	NULL
,	NULL
OA-treated	NULL
)	NULL
were	NULL
separated	NULL
by	NULL
Q	NULL
Sepharose	NULL
and	NULL
then	NULL
Mono	NULL
Q	NULL
column	NULL
chromatography	NULL
.	NULL

The	NULL
fractions	NULL
were	NULL
assayed	NULL
for	NULL
phosphorylation	NULL
of	NULL
S6	NULL
peptide	NULL
.	NULL

TUR	NULL
clone	NULL
was	NULL
isolated	NULL
from	NULL
a	NULL
single	NULL
U-937	NULL
cell	NULL
selected	NULL
for	NULL
resistance	NULL
to	NULL
the	NULL
growth-inhibitory	NULL
effects	NULL
of	NULL
5	NULL
nm	NULL
TPA	NULL
.	NULL

This	NULL
variant	NULL
fails	NULL
to	NULL
exhibit	NULL
growth	NULL
arrest	NULL
,	NULL
adherence	NULL
,	NULL
or	NULL
increases	NULL
in	NULL
e-naphthylacetate	NULL
esterase	NULL
staining	NULL
,	NULL
all	NULL
characteristics	NULL
of	NULL
the	NULL
differentiated	NULL
monocytic	NULL
phenotype	NULL
,	NULL
when	NULL
exposed	NULL
to	NULL
TPA	NULL
at	NULL
concentrations	NULL
as	NULL
high	NULL
as	NULL
500	NULL
nm	NULL
(	NULL
36	NULL
)	NULL
.	NULL

Other	NULL
work	NULL
has	NULL
demonstrated	NULL
that	NULL
monocytic	NULL
differentiation	NULL
of	NULL
U-937	NULL
cells	NULL
is	NULL
also	NULL
associated	NULL
with	NULL
increased	NULL
expression	NULL
of	NULL
the	NULL
EGR-1	NULL
gene	NULL
(	NULL
6	NULL
)	NULL
.	NULL

Similar	NULL
findings	NULL
were	NULL
obtained	NULL
with	NULL
additional	NULL
in-ducers	NULL
of	NULL
U-937	NULL
cell	NULL
differentiation	NULL
,	NULL
including	NULL
okadaic	NULL
acid	NULL
,	NULL
and	NULL
during	NULL
activation	NULL
of	NULL
resting	NULL
human	NULL
peripheral	NULL
blood	NULL
Cell	NULL
Growth	NULL
&	NULL
Differentiation	NULL
(	NULL
-	NULL
)	NULL
[	NULL
wj	NULL
19°N	NULL
S6P	NULL
Phosphorylation	NULL
(	NULL
pmol/min	NULL
)	NULL
(	NULL
-	NULL
)	NULL
°	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
Fraction	NULL
Number	NULL
Fig	NULL
.	NULL

7.	NULL
.	NULL

Activation	NULL
of	NULL
pp90	NULL
``	NULL
**	NULL
in	NULL
TUR	NULL
cells	NULL
.	NULL

TUR	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
TPA	NULL
or	NULL
okadaic	NULL
acid	NULL
for	NULL
30	NULL
min	NULL
and	NULL
3	NULL
h	NULL
,	NULL
respectively	NULL
.	NULL

Soluble	NULL
proteins	NULL
(	NULL
C	NULL
,	NULL
control	NULL
;	NULL
@	NULL
,	NULL
TPA-treated	NULL
;	NULL
O	NULL
,	NULL
OA-treated	NULL
)	NULL
were	NULL
separated	NULL
by	NULL
Q	NULL
Sepharose	NULL
and	NULL
then	NULL
Mono	NULL
Q	NULL
column	NULL
chromatography	NULL
.	NULL

The	NULL
fractions	NULL
were	NULL
assayed	NULL
for	NULL
phosphorylation	NULL
of	NULL
S6	NULL
peptide	NULL
.	NULL

monocytes	NULL
(	NULL
6	NULL
,	NULL
13	NULL
)	NULL
.	NULL

More	NULL
importantly	NULL
,	NULL
recent	NULL
work	NULL
has	NULL
demonstrated	NULL
that	NULL
EGR-1	NULL
expression	NULL
is	NULL
required	NULL
for	NULL
induction	NULL
of	NULL
monocytic	NULL
differentiation	NULL
(	NULL
14	NULL
)	NULL
.	NULL

In	NULL
the	NULL
present	NULL
studies	NULL
,	NULL
TPA	NULL
induced	NULL
little	NULL
EGR-1	NULL
expression	NULL
in	NULL
TUR	NULL
cells	NULL
,	NULL
whereas	NULL
okadaic	NULL
acid	NULL
treatment	NULL
was	NULL
associated	NULL
with	NULL
induction	NULL
of	NULL
this	NULL
gene	NULL
.	NULL

Okadaic	NULL
acid	NULL
is	NULL
an	NULL
inhibitor	NULL
of	NULL
serine/threonine	NULL
protein	NULL
phosphatases	NULL
(	NULL
37-39	NULL
)	NULL
and	NULL
in	NULL
earlier	NULL
studies	NULL
was	NULL
found	NULL
to	NULL
induce	NULL
monocytic	NULL
differentiation	NULL
of	NULL
U-937	NULL
cells	NULL
(	NULL
40	NULL
)	NULL
.	NULL

Treatment	NULL
of	NULL
TUR	NULL
cells	NULL
with	NULL
okadaic	NULL
acid	NULL
was	NULL
also	NULL
associated	NULL
with	NULL
growth	NULL
arrest	NULL
and	NULL
the	NULL
appearance	NULL
of	NULL
a	NULL
differentiated	NULL
monocytic	NULL
phenotype	NULL
(	NULL
36	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
indicated	NULL
that	NULL
signaling	NULL
events	NULL
associated	NULL
with	NULL
induction	NULL
of	NULL
the	NULL
EGR-1	NULL
gene	NULL
and	NULL
monocytic	NULL
differentiation	NULL
are	NULL
regulated	NULL
at	NULL
least	NULL
in	NULL
part	NULL
by	NULL
serine/threonine	NULL
protein	NULL
phosphorylation	NULL
.	NULL

Several	NULL
serine/threonine	NULL
protein	NULL
kinases	NULL
have	NULL
been	NULL
identified	NULL
that	NULL
participate	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
cell	NULL
growth	NULL
and	NULL
differentiation	NULL
.	NULL

TPA	NULL
activates	NULL
the	NULL
serine/threonine-specific	NULL
PKC	NULL
(	NULL
4	NULL
)	NULL
,	NULL
and	NULL
thus	NULL
this	NULL
kinase	NULL
functions	NULL
in	NULL
initial	NULL
signals	NULL
that	NULL
contribute	NULL
to	NULL
monocytic	NULL
differentiation	NULL
.	NULL

However	NULL
,	NULL
studies	NULL
with	NULL
the	NULL
TPA-resistant	NULL
TUR	NULL
clone	NULL
suggest	NULL
that	NULL
other	NULL
events	NULL
,	NULL
potentially	NULL
downstream	NULL
of	NULL
PKC	NULL
,	NULL
can	NULL
be	NULL
activated	NULL
by	NULL
okadaic	NULL
acid	NULL
and	NULL
thereby	NULL
induce	NULL
a	NULL
monocytic	NULL
phenotype	NULL
.	NULL

Indeed	NULL
,	NULL
characterization	NULL
of	NULL
the	NULL
TUR	NULL
variant	NULL
has	NULL
demonstrated	NULL
decreased	NULL
levels	NULL
of	NULL
PKC	NULL
isoforms	NULL
(	NULL
36	NULL
)	NULL
.	NULL

Similar	NULL
decreases	NULL
in	NULL
PKC	NULL
expression	NULL
have	NULL
been	NULL
reported	NULL
for	NULL
TPA-resistant	NULL
HL-60	NULL
myeloid	NULL
leukemia	NULL
cells	NULL
(	NULL
41	NULL
,	NULL
42	NULL
)	NULL
.	NULL

The	NULL
present	NULL
studies	NULL
have	NULL
therefore	NULL
focused	NULL
on	NULL
two	NULL
other	NULL
serine/threonine	NULL
protein	NULL
kinases	NULL
,	NULL
pp70°°®	NULL
and	NULL
pp90	NULL
``	NULL
®	NULL
,	NULL
that	NULL
phosphorylate	NULL
the	NULL
408	NULL
ribosomal	NULL
S6	NULL
protein	NULL
.	NULL

Previous	NULL
work	NULL
has	NULL
shown	NULL
that	NULL
mitogen-induced	NULL
growth	NULL
is	NULL
associated	NULL
with	NULL
phosphorylation	NULL
of	NULL
S6	NULL
protein	NULL
(	NULL
29	NULL
)	NULL
.	NULL

TPA-induced	NULL
mitogenesis	NULL
of	NULL
quiescent	NULL
cells	NULL
is	NULL
associated	NULL
with	NULL
activation	NULL
of	NULL
pp70°°¢	NULL
(	NULL
31	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
selective	NULL
inhibition	NULL
of	NULL
pp70°°	NULL
``	NULL
with	NULL
rapamycin	NULL
blocks	NULL
interleukin	NULL
2-induced	NULL
entry	NULL
of	NULL
T-cells	NULL
into	NULL
S	NULL
phase	NULL
(	NULL
32	NULL
)	NULL
.	NULL

Of	NULL
interest	NULL
,	NULL
TPA	NULL
treatment	NULL
of	NULL
U-937	NULL
cells	NULL
had	NULL
no	NULL
detectable	NULL
effect	NULL
on	NULL
pp70°®*	NULL
.	NULL

Furthermore	NULL
,	NULL
rapamycin	NULL
,	NULL
an	NULL
inhibitor	NULL
of	NULL
pp70°°®	NULL
,	NULL
failed	NULL
to	NULL
block	NULL
TPA-induced	NULL
EGR-1	NULL
expression	NULL
and	NULL
appearance	NULL
of	NULL
the	NULL
monocytic	NULL
phenotype	NULL
.	NULL

The	NULL
finding	NULL
that	NULL
okadaic	NULL
acid	NULL
treatment	NULL
of	NULL
both	NULL
U-937	NULL
and	NULL
TUR	NULL
cells	NULL
has	NULL
no	NULL
effect	NULL
on	NULL
this	NULL
kinase	NULL
also	NULL
supported	NULL
the	NULL
lack	NULL
of	NULL
involvement	NULL
of	NULL
pp70°°K	NULL
in	NULL
monocytic	NULL
differentiation	NULL
.	NULL

Thus	NULL
,	NULL
pp70°°	NULL
would	NULL
appear	NULL
to	NULL
be	NULL
activated	NULL
during	NULL
mitogenesis	NULL
,	NULL
but	NULL
not	NULL
differentiation	NULL
of	NULL
certain	NULL
cell	NULL
types	NULL
.	NULL

Although	NULL
also	NULL
phosphorylates	NULL
S6	NULL
protein	NULL
,	NULL
this	NULL
ki-nase	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
pp70°°®	NULL
,	NULL
exhibits	NULL
phosphotransferase	NULL
activity	NULL
toward	NULL
a	NULL
variety	NULL
of	NULL
other	NULL
substrates	NULL
.	NULL

For	NULL
example	NULL
,	NULL
activated	NULL
pp90	NULL
``	NULL
®	NULL
and	NULL
its	NULL
homologues	NULL
phosphorylate	NULL
MAP2	NULL
(	NULL
31	NULL
)	NULL
,	NULL
c-fos	NULL
(	NULL
27	NULL
)	NULL
,	NULL
histone	NULL
H3	NULL
(	NULL
27	NULL
)	NULL
,	NULL
lamin	NULL
C	NULL
(	NULL
43	NULL
)	NULL
,	NULL
and	NULL
glycogen	NULL
synthase	NULL
(	NULL
44	NULL
)	NULL
.	NULL

Previous	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
the	NULL
pp90	NULL
``	NULL
®*	NULL
signaling	NULL
cascade	NULL
transduces	NULL
growth-regulatory	NULL
signals	NULL
to	NULL
the	NULL
nucleus	NULL
,	NULL
whereas	NULL
less	NULL
is	NULL
known	NULL
about	NULL
the	NULL
role	NULL
of	NULL
this	NULL
kinase	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
differentiation	NULL
.	NULL

The	NULL
present	NULL
results	NULL
demonstrate	NULL
that	NULL
pp90	NULL
``	NULL
®	NULL
is	NULL
also	NULL
activated	NULL
during	NULL
monocytic	NULL
differentiation	NULL
.	NULL

TPA	NULL
treatment	NULL
of	NULL
U-937	NULL
cells	NULL
,	NULL
but	NULL
not	NULL
the	NULL
TUR	NULL
variant	NULL
,	NULL
was	NULL
associated	NULL
with	NULL
activation	NULL
of	NULL
pp90'®	NULL
as	NULL
determined	NULL
by	NULL
increased	NULL
phosphorylation	NULL
of	NULL
S6	NULL
peptide	NULL
.	NULL

Activation	NULL
of	NULL
pp90	NULL
``	NULL
**	NULL
was	NULL
also	NULL
found	NULL
during	NULL
okadaic	NULL
acid-induced	NULL
differentiation	NULL
of	NULL
both	NULL
U-937	NULL
and	NULL
TUR	NULL
cells	NULL
.	NULL

Although	NULL
the	NULL
mechanisms	NULL
responsible	NULL
for	NULL
this	NULL
activation	NULL
of	NULL
pp90	NULL
``	NULL
®	NULL
in	NULL
these	NULL
TPA-	NULL
and	NULL
okadaic	NULL
acid-treated	NULL
cells	NULL
have	NULL
not	NULL
been	NULL
defined	NULL
in	NULL
the	NULL
present	NULL
studies	NULL
,	NULL
previous	NULL
work	NULL
has	NULL
shown	NULL
that	NULL
pp90	NULL
``	NULL
®	NULL
``	NULL
is	NULL
activated	NULL
by	NULL
MAP	NULL
kinase	NULL
(	NULL
23	NULL
,	NULL
24	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
MAP	NULL
kinase	NULL
and	NULL
pp90	NULL
``	NULL
``	NULL
exhibit	NULL
coordinate	NULL
temporal	NULL
regulation	NULL
and	NULL
spatial	NULL
distribution	NULL
following	NULL
addition	NULL
of	NULL
growth	NULL
factors	NULL
to	NULL
serum-deprived	NULL
cells	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Other	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
MAP	NULL
kinase	NULL
is	NULL
activated	NULL
in	NULL
TPA-induced	NULL
U-937	NULL
cells	NULL
(	NULL
26	NULL
)	NULL
,	NULL
and	NULL
we	NULL
have	NULL
obtained	NULL
similar	NULL
findings	NULL
in	NULL
okadaic	NULL
acid-treated	NULL
U-937	NULL
and	NULL
TUR	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Stimulation	NULL
of	NULL
MAP	NULL
kinase	NULL
activity	NULL
was	NULL
detectable	NULL
at	NULL
low	NULL
levels	NULL
in	NULL
TPA-treated	NULL
TUR	NULL
cells	NULL
and	NULL
was	NULL
less	NULL
pronounced	NULL
than	NULL
that	NULL
obtained	NULL
with	NULL
okadaic	NULL
acid	NULL
or	NULL
during	NULL
induction	NULL
of	NULL
U-937	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
activation	NULL
of	NULL
MAP	NULL
kinase	NULL
may	NULL
be	NULL
responsible	NULL
for	NULL
stimulation	NULL
of	NULL
activity	NULL
during	NULL
both	NULL
mitogenesis	NULL
and	NULL
induction	NULL
of	NULL
monocytic	NULL
differentiation	NULL
.	NULL

Certain	NULL
insights	NULL
are	NULL
available	NULL
regarding	NULL
the	NULL
relationship	NULL
between	NULL
activation	NULL
of	NULL
the	NULL
MAP	NULL
kinase/pp90	NULL
``	NULL
®	NULL
``	NULL
signaling	NULL
cascade	NULL
and	NULL
induction	NULL
of	NULL
early	NULL
response	NULL
gene	NULL
expression	NULL
.	NULL

MAP	NULL
kinase	NULL
phosphorylates	NULL
c-Jun	NULL
and	NULL
thereby	NULL
may	NULL
contribute	NULL
to	NULL
Jun/AP-1-mediated	NULL
activation	NULL
of	NULL
c-jun	NULL
gene	NULL
transcription	NULL
(	NULL
26	NULL
)	NULL
.	NULL

pp90	NULL
``	NULL
**	NULL
phosphorylates	NULL
a	NULL
COOH-terminal	NULL
serine	NULL
in	NULL
c-Fos	NULL
which	NULL
is	NULL
necessary	NULL
for	NULL
transcriptional	NULL
transrepression	NULL
of	NULL
the	NULL
c-fos	NULL
promoter	NULL
(	NULL
27	NULL
,	NULL
45	NULL
)	NULL
.	NULL

This	NULL
COOH-terminal	NULL
region	NULL
of	NULL
c-Fos	NULL
is	NULL
also	NULL
required	NULL
for	NULL
down-regulation	NULL
of	NULL
EGR-1	NULL
gene	NULL
transcription	NULL
after	NULL
mitogenic	NULL
stimulation	NULL
(	NULL
46	NULL
)	NULL
.	NULL

The	NULL
target	NULL
for	NULL
this	NULL
repression	NULL
is	NULL
the	NULL
SRE	NULL
or	NULL
CArG	NULL
box	NULL
(	NULL
46	NULL
)	NULL
.	NULL

pp90	NULL
``	NULL
*	NULL
``	NULL
phosphorylates	NULL
SRF	NULL
in	NULL
vitro	NULL
at	NULL
the	NULL
same	NULL
site	NULL
(	NULL
serine	NULL
103	NULL
)	NULL
that	NULL
is	NULL
phosphorylated	NULL
in	NULL
vivo	NULL
after	NULL
growth	NULL
factor	NULL
stimulation	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Since	NULL
SRF	NULL
also	NULL
interacts	NULL
with	NULL
the	NULL
SRE	NULL
(	NULL
47	NULL
,	NULL
48	NULL
)	NULL
,	NULL
and	NULL
phosphorylation	NULL
at	NULL
serine	NULL
103	NULL
enhances	NULL
the	NULL
affinity	NULL
of	NULL
SRF	NULL
binding	NULL
to	NULL
the	NULL
SRE	NULL
(	NULL
28	NULL
)	NULL
,	NULL
pp90	NULL
``	NULL
¢	NULL
may	NULL
coordinate	NULL
the	NULL
transcription	NULL
of	NULL
genes	NULL
regulated	NULL
by	NULL
this	NULL
element	NULL
.	NULL

Other	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
the	NULL
SRE	NULL
interacts	NULL
with	NULL
both	NULL
SRF	NULL
and	NULL
p62	NULL
``	NULL
,	NULL
and	NULL
that	NULL
phosphorylation	NULL
of	NULL
p62	NULL
``	NULL
by	NULL
MAP	NULL
kinase	NULL
stimulates	NULL
formation	NULL
of	NULL
this	NULL
ternary	NULL
complex	NULL
(	NULL
49	NULL
)	NULL
.	NULL

The	NULL
present	NULL
work	NULL
demonstrates	NULL
that	NULL
TPA-induced	NULL
EGR-1	NULL
gene	NULL
transcription	NULL
in	NULL
U-937	NULL
cells	NULL
is	NULL
conferred	NULL
by	NULL
the	NULL
region	NULL
of	NULL
the	NULL
EGR-1	NULL
promoter	NULL
containing	NULL
the	NULL
first	NULL
and	NULL
second	NULL
CArG	NULL
elements	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
there	NULL
was	NULL
no	NULL
detectable	NULL
activation	NULL
of	NULL
EGR-1	NULL
promoter-reporter	NULL
constructs	NULL
in	NULL
TPA-treated	NULL
TUR	NULL
cells	NULL
.	NULL

Moreover	NULL
,	NULL
as	NULL
previously	NULL
demonstrated	NULL
in	NULL
okadaic	NULL
acid-treated	NULL
U-937	NULL
cells	NULL
(	NULL
13	NULL
)	NULL
,	NULL
the	NULL
present	NULL
work	NULL
shows	NULL
that	NULL
the	NULL
first	NULL
CArG	NULL
element	NULL
confers	NULL
okadaic	NULL
acid	NULL
inducibility	NULL
of	NULL
EGR-1	NULL
transcription	NULL
in	NULL
TUR	NULL
cells	NULL
.	NULL

The	NULL
findings	NULL
thus	NULL
suggest	NULL
that	NULL
activation	NULL
of	NULL
the	NULL
MAP	NULL
kinase/pp90	NULL
``	NULL
*®	NULL
cascade	NULL
may	NULL
contribute	NULL
to	NULL
induction	NULL
of	NULL
EGR-1	NULL
transcription	NULL
through	NULL
phosphorylation	NULL
of	NULL
serum	NULL
response	NULL
factor	NULL
and	NULL
p62	NULL
``	NULL
.	NULL

Direct	NULL
support	NULL
for	NULL
this	NULL
mechanism	NULL
would	NULL
be	NULL
provided	NULL
by	NULL
increased	NULL
binding	NULL
of	NULL
these	NULL
factors	NULL
to	NULL
the	NULL
proximal	NULL
CArG	NULL
sites	NULL
in	NULL
the	NULL
EGR-1	NULL
promoter	NULL
.	NULL

However	NULL
,	NULL
263	NULL
264	NULL
Induction	NULL
of	NULL
EGR-1	NULL
Gene	NULL
Transcription	NULL
we	NULL
have	NULL
been	NULL
unable	NULL
thus	NULL
far	NULL
to	NULL
demonstrate	NULL
a	NULL
significant	NULL
and	NULL
reproducible	NULL
shift	NULL
in	NULL
electrophoretic	NULL
mobility	NULL
patterns	NULL
using	NULL
the	NULL
proximal	NULL
CArG	NULL
box	NULL
and	NULL
nuclear	NULL
proteins	NULL
from	NULL
induced	NULL
U-937	NULL
cells	NULL
.	NULL

Finally	NULL
,	NULL
although	NULL
MAP	NULL
kinase/pp90*	NULL
activation	NULL
and	NULL
EGR-1	NULL
induction	NULL
have	NULL
been	NULL
associated	NULL
with	NULL
mitogenesis	NULL
,	NULL
the	NULL
present	NULL
findings	NULL
support	NULL
the	NULL
involvement	NULL
of	NULL
these	NULL
signaling	NULL
pathways	NULL
in	NULL
the	NULL
differentiation	NULL
of	NULL
myeloid	NULL
leukemia	NULL
cells	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Cell	NULL
Culture	NULL
.	NULL

U-937	NULL
cells	NULL
(	NULL
50	NULL
)	NULL
and	NULL
a	NULL
TPA-unresponsive	NULL
U-937	NULL
variant	NULL
,	NULL
designated	NULL
TUR	NULL
(	NULL
36	NULL
)	NULL
,	NULL
were	NULL
grown	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
containing	NULL
10	NULL
%	NULL
heat-inactivated	NULL
fetal	NULL
bovine	NULL
serum	NULL
supplemented	NULL
with	NULL
100	NULL
units/ml	NULL
penicillin	NULL
,	NULL
100	NULL
pg/ml	NULL
streptomycin	NULL
,	NULL
and	NULL
2	NULL
mm	NULL
i-glutamine	NULL
.	NULL

Cells	NULL
were	NULL
exposed	NULL
to	NULL
32	NULL
nm	NULL
TPA	NULL
(	NULL
Sigma	NULL
Chemical	NULL
Co.	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
,	NULL
40	NULL
ng/ml	NULL
okadaic	NULL
acid	NULL
(	NULL
Moana	NULL
Bioproducts	NULL
,	NULL
Honolulu	NULL
,	NULL
H1	NULL
}	NULL
,	NULL
and	NULL
80	NULL
nm	NULL
rapamycin	NULL
(	NULL
Drug	NULL
Synthesis	NULL
and	NULL
Chemistry	NULL
Branch	NULL
,	NULL
National	NULL
Cancer	NULL
Institute	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

RNA	NULL
Isolation	NULL
and	NULL
Northern	NULL
Blot	NULL
Analysis	NULL
.	NULL

Total	NULL
cellular	NULL
RNA	NULL
was	NULL
isolated	NULL
by	NULL
the	NULL
guanidine	NULL
isothiocyanate-cesium	NULL
chloride	NULL
method	NULL
(	NULL
51	NULL
)	NULL
.	NULL

The	NULL
RNA	NULL
(	NULL
20	NULL
pg	NULL
)	NULL
was	NULL
analyzed	NULL
by	NULL
electrophoresis	NULL
in	NULL
1	NULL
%	NULL
agarose-2.2	NULL
m	NULL
formaldehyde	NULL
gels	NULL
and	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
filters	NULL
.	NULL

Hybridizations	NULL
were	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
6	NULL
)	NULL
with	NULL
the	NULL
following	NULL
°°P-labeled	NULL
DNA	NULL
probes	NULL
:	NULL
(	NULL
a	NULL
)	NULL
the	NULL
0.7-kb	NULL
non-zinc	NULL
finger	NULL
insert	NULL
of	NULL
a	NULL
murine	NULL
Egr-1	NULL
complementary	NULL
DNA	NULL
(	NULL
10	NULL
)	NULL
;	NULL
and	NULL
(	NULL
b	NULL
)	NULL
the	NULL
2.0-kb	NULL
Pstl	NULL
insert	NULL
of	NULL
a	NULL
chicken	NULL
B-actin	NULL
gene	NULL
purified	NULL
from	NULL
the	NULL
pA1	NULL
plasmid	NULL
(	NULL
52	NULL
)	NULL
.	NULL

Reporter	NULL
Assays	NULL
.	NULL

The	NULL
pEGR-1P1.2	NULL
,	NULL
pE425	NULL
,	NULL
pE395	NULL
,	NULL
pE359	NULL
,	NULL
and	NULL
pE7O	NULL
constructs	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
(	NULL
46	NULL
)	NULL
.	NULL

The	NULL
vectors	NULL
were	NULL
transfected	NULL
into	NULL
cells	NULL
using	NULL
the	NULL
DEAE-dextran	NULL
technique	NULL
(	NULL
53	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
2	NULL
X	NULL
10	NULL
``	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
washed	NULL
with	NULL
PBS	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
resuspended	NULL
in	NULL
1	NULL
mi	NULL
of	NULL
20	NULL
mm	NULL
Tris-HCI	NULL
(	NULL
pH	NULL
7.4	NULL
)	NULL
buffer	NULL
containing	NULL
0.5	NULL
mg/m	NULL
!	NULL

DEAE-dextran	NULL
,	NULL
8	NULL
pg	NULL
plasmid	NULL
,	NULL
140	NULL
mm	NULL
NaCl	NULL
,	NULL
5	NULL
mm	NULL
KCI	NULL
,	NULL
375	NULL
pm	NULL
Na	NULL
;	NULL
HPOq+7H,0	NULL
,	NULL
1	NULL
mm	NULL
MgCl	NULL
,	NULL
and	NULL
675	NULL
um	NULL
CaCl	NULL
,	NULL
,	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
incubated	NULL
at	NULL
37°C	NULL
for	NULL
45	NULL
min	NULL
,	NULL
washed	NULL
with	NULL
media	NULL
containing	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
,	NULL
resuspended	NULL
in	NULL
complete	NULL
media	NULL
,	NULL
and	NULL
then	NULL
incubated	NULL
at	NULL
37°C	NULL
.	NULL

Thirty-six	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
distributed	NULL
equally	NULL
into	NULL
two	NULL
ali-quots	NULL
;	NULL
one	NULL
aliquot	NULL
served	NULL
as	NULL
a	NULL
control	NULL
,	NULL
and	NULL
the	NULL
other	NULL
was	NULL
treated	NULL
with	NULL
TPA	NULL
or	NULL
okadaic	NULL
acid	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
harvested	NULL
after	NULL
9	NULL
h	NULL
and	NULL
lysed	NULL
by	NULL
three	NULL
cycles	NULL
of	NULL
freezing	NULL
and	NULL
thawing	NULL
in	NULL
0.25	NULL
m	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
7.8	NULL
)	NULL
and	NULL
1	NULL
mm	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
.	NULL

Equal	NULL
amounts	NULL
of	NULL
the	NULL
cell	NULL
extracts	NULL
were	NULL
incubated	NULL
with	NULL
0.025	NULL
uCi	NULL
chloramphenicol	NULL
,	NULL
0.15	NULL
m	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
7.8	NULL
)	NULL
,	NULL
and	NULL
0.4	NULL
mm	NULL
acetyl-CoA	NULL
for	NULL
1	NULL
h	NULL
at	NULL
37°C	NULL
.	NULL

The	NULL
enzyme	NULL
assay	NULL
was	NULL
terminated	NULL
by	NULL
addition	NULL
of	NULL
ethyl	NULL
acetate	NULL
.	NULL

The	NULL
organic	NULL
layer	NULL
containing	NULL
the	NULL
acetylated	NULL
[	NULL
**C	NULL
)	NULL
chloramphenicol	NULL
was	NULL
separated	NULL
by	NULL
thin-layer	NULL
chromatography	NULL
using	NULL
chloro-form-methanol	NULL
(	NULL
95	NULL
%	NULL
/5	NULL
%	NULL
;	NULL
v/v	NULL
)	NULL
.	NULL

Following	NULL
autoradiography	NULL
,	NULL
both	NULL
acetylated	NULL
and	NULL
unacetylated	NULL
forms	NULL
of	NULL
[	NULL
'*C	NULL
)	NULL
chloram-phenicol	NULL
were	NULL
cut	NULL
from	NULL
the	NULL
plates	NULL
,	NULL
and	NULL
the	NULL
conversion	NULL
of	NULL
chloramphenicol	NULL
to	NULL
the	NULL
acetylated	NULL
form	NULL
was	NULL
calculated	NULL
by	NULL
measurement	NULL
of	NULL
radioactivity	NULL
in	NULL
a	NULL
B-scintillation	NULL
counter	NULL
.	NULL

Subcellular	NULL
Fractionation	NULL
.	NULL

Cells	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
ice-cold	NULL
PBS	NULL
and	NULL
lysed	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
hypotonic	NULL
lysis	NULL
buffer	NULL
(	NULL
1	NULL
mm	NULL
-	NULL
ethyleneglycol	NULL
-	NULL
bis	NULL
(	NULL
B-aminoethyl	NULL
-	NULL
ether	NULL
)	NULL
-N	NULL
,	NULL
N	NULL
,	NULL
N	NULL
'	NULL
,	NULL
N'-tetraacetic	NULL
acid	NULL
,	NULL
1	NULL
mm	NULL
EDTA	NULL
,	NULL
10	NULL
mm	NULL
B-glycerophosphate	NULL
,	NULL
1	NULL
mm	NULL
sodium	NULL
orthovanadate	NULL
,	NULL
2	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
10	NULL
mm	NULL
KCl	NULL
,	NULL
1	NULL
mm	NULL
dithiothreitol	NULL
,	NULL
40	NULL
ug/ml	NULL
phenylmethylsulfony	NULL
!	NULL

fluoride	NULL
,	NULL
and	NULL
10	NULL
ug/m	NULL
!	NULL

of	NULL
both	NULL
leupeptin	NULL
and	NULL
aprotinin	NULL
)	NULL
.	NULL

The	NULL
cell	NULL
suspension	NULL
was	NULL
incubated	NULL
on	NULL
ice	NULL
for	NULL
30	NULL
min	NULL
to	NULL
allow	NULL
swelling	NULL
.	NULL

After	NULL
Dounce	NULL
homogenization	NULL
of	NULL
the	NULL
cells	NULL
(	NULL
20-25	NULL
strokes	NULL
,	NULL
tight	NULL
pestle	NULL
A	NULL
)	NULL
,	NULL
the	NULL
lysate	NULL
was	NULL
loaded	NULL
onto	NULL
1	NULL
ml	NULL
of	NULL
1	NULL
m	NULL
sucrose	NULL
in	NULL
lysis	NULL
buffer	NULL
and	NULL
centrifuged	NULL
at	NULL
1,600	NULL
x	NULL
g	NULL
for	NULL
15	NULL
min	NULL
.	NULL

The	NULL
supernatant	NULL
above	NULL
the	NULL
sucrose	NULL
gradient	NULL
was	NULL
again	NULL
centrifuged	NULL
at	NULL
150,000	NULL
x	NULL
g	NULL
for	NULL
30	NULL
min	NULL
.	NULL

The	NULL
resulting	NULL
soluble	NULL
fraction	NULL
was	NULL
adjusted	NULL
to	NULL
0.5	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
0.1	NULL
%	NULL
deoxy-cholate	NULL
,	NULL
and	NULL
0.1	NULL
%	NULL
Brij	NULL
35	NULL
and	NULL
used	NULL
as	NULL
the	NULL
cytosolic	NULL
fraction	NULL
.	NULL

Immunoblot	NULL
Analysis	NULL
.	NULL

Phosphorylation	NULL
of	NULL
pp70°°	NULL
``	NULL
and	NULL
pp90	NULL
``	NULL
®®	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Proteins	NULL
were	NULL
separated	NULL
in	NULL
7.5	NULL
%	NULL
SDS-polyacrylamide	NULL
gels	NULL
and	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
paper	NULL
.	NULL

The	NULL
residual	NULL
binding	NULL
sites	NULL
were	NULL
first	NULL
blocked	NULL
by	NULL
incubating	NULL
the	NULL
filter	NULL
in	NULL
5	NULL
%	NULL
dry	NULL
milk	NULL
in	NULL
PBST	NULL
(	NULL
PBS-0.05	NULL
%	NULL
Tween	NULL
20	NULL
)	NULL
for	NULL
1	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

The	NULL
filters	NULL
were	NULL
then	NULL
incubated	NULL
with	NULL
either	NULL
a	NULL
rabbit	NULL
anti-pp70®°	NULL
``	NULL
or	NULL
a	NULL
rabbit	NULL
anti-pp90	NULL
``	NULL
®	NULL
antiserum	NULL
for	NULL
1	NULL
h	NULL
with	NULL
shaking	NULL
.	NULL

After	NULL
washing	NULL
three	NULL
times	NULL
with	NULL
PBST	NULL
,	NULL
the	NULL
blots	NULL
were	NULL
incubated	NULL
with	NULL
anti-rabbit	NULL
IgG	NULL
peroxidase	NULL
conjugate	NULL
(	NULL
Sigma	NULL
)	NULL
.	NULL

The	NULL
antigen-antibody	NULL
complexes	NULL
were	NULL
visualized	NULL
by	NULL
chemilu-minescence	NULL
(	NULL
ECL	NULL
detection	NULL
system	NULL
;	NULL
Amersham	NULL
,	NULL
Arlington	NULL
Heights	NULL
,	NULL
IL	NULL
)	NULL
.	NULL

Partial	NULL
Purification	NULL
of	NULL
pp90	NULL
``	NULL
**	NULL
Activity	NULL
.	NULL

The	NULL
cytosolic	NULL
fraction	NULL
was	NULL
applied	NULL
to	NULL
a	NULL
Q	NULL
Sepharose	NULL
Fast	NULL
Flow	NULL
column	NULL
(	NULL
1.0	NULL
ml	NULL
;	NULL
Pharmacia	NULL
,	NULL
Piscataway	NULL
,	NULL
NJ	NULL
)	NULL
.	NULL

After	NULL
washing	NULL
with	NULL
buffer	NULL
A	NULL
[	NULL
20	NULL
mm	NULL
Tris-HCI	NULL
(	NULL
pH	NULL
7.4	NULL
)	NULL
,	NULL
0.5	NULL
mm	NULL
ethyleneglycol	NULL
bis	NULL
(	NULL
B-aminoethyl	NULL
ether	NULL
)	NULL
-N	NULL
,	NULL
N	NULL
,	NULL
N	NULL
'	NULL
,	NULL
N	NULL
'	NULL
-tetraacetic	NULL
acid	NULL
,	NULL
0.5	NULL
mm	NULL
EDTA	NULL
,	NULL
and	NULL
10	NULL
mm	NULL
B-mercaptoethanol	NULL
]	NULL
,	NULL
proteins	NULL
were	NULL
eluted	NULL
with	NULL
3	NULL
mi	NULL
of	NULL
0.2	NULL
m	NULL
NaCl-buffer	NULL
A	NULL
,	NULL
adjusted	NULL
to	NULL
0.02	NULL
m	NULL
NaCl	NULL
with	NULL
buffer	NULL
A	NULL
,	NULL
and	NULL
applied	NULL
to	NULL
a	NULL
Mono	NULL
Q	NULL
column	NULL
(	NULL
HR	NULL
5/5	NULL
;	NULL
Pharmacia	NULL
)	NULL
.	NULL

The	NULL
column	NULL
was	NULL
washed	NULL
with	NULL
buffer	NULL
A	NULL
.	NULL

Protein	NULL
was	NULL
eluted	NULL
with	NULL
a	NULL
linear	NULL
0.0-0.5	NULL
m	NULL
NaCl-buffer	NULL
A	NULL
gradient	NULL
.	NULL

Fractions	NULL
were	NULL
assayed	NULL
for	NULL
pp90	NULL
``	NULL
**	NULL
activity	NULL
by	NULL
incubation	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
50	NULL
pm	NULL
S6	NULL
peptide	NULL
(	NULL
RRRLSSLRA	NULL
)	NULL
,	NULL
20	NULL
pm	NULL
[	NULL
y-2P	NULL
]	NULL
JATP	NULL
,	NULL
10	NULL
mm	NULL
MgCl	NULL
;	NULL
,	NULL
and	NULL
0.4	NULL
mm	NULL
dithiothreitol	NULL
.	NULL

After	NULL
incubation	NULL
for	NULL
15	NULL
min	NULL
at	NULL
30°C	NULL
,	NULL
25	NULL
pl	NULL
of	NULL
the	NULL
reaction	NULL
mixture	NULL
were	NULL
loaded	NULL
onto	NULL
phosphocellulose	NULL
discs	NULL
(	NULL
GIBCO-BRL	NULL
,	NULL
Grand	NULL
Island	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

The	NULL
discs	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
1	NULL
%	NULL
phosphoric	NULL
acid	NULL
and	NULL
then	NULL
with	NULL
water	NULL
before	NULL
scintillation	NULL
counting	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Huberman	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Callahan	NULL
,	NULL
M.	NULL
P.	NULL
Induction	NULL
of	NULL
terminal	NULL
differentiation	NULL
of	NULL
human	NULL
promyelocytic	NULL
leukemia	NULL
cells	NULL
by	NULL
tumor-promoting	NULL
agents	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
76	NULL
:	NULL
1293-1297	NULL
,	NULL
1979	NULL
.	NULL

2	NULL
.	NULL

Lotem	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Sachs	NULL
,	NULL
L.	NULL
Regulation	NULL
of	NULL
normal	NULL
differentiation	NULL
in	NULL
mouse	NULL
and	NULL
human	NULL
myeloid	NULL
leukemic	NULL
cells	NULL
by	NULL
phorbol	NULL
esters	NULL
and	NULL
the	NULL
mechanism	NULL
of	NULL
tumor	NULL
production	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
76	NULL
:	NULL
5158-5162	NULL
,	NULL
1979	NULL
.	NULL

3	NULL
.	NULL

Rovera	NULL
,	NULL
G.	NULL
,	NULL
O'Brien	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
and	NULL
Diamond	NULL
,	NULL
L.	NULL
Induction	NULL
of	NULL
differentiation	NULL
in	NULL
human	NULL
promyelocytic	NULL
leukemia	NULL
cells	NULL
by	NULL
tumor	NULL
promoters	NULL
.	NULL

Science	NULL
(	NULL
Washington	NULL
DC	NULL
)	NULL
,	NULL
204	NULL
:	NULL
868-870	NULL
,	NULL
1979	NULL
.	NULL

4	NULL
.	NULL

Nishizuka	NULL
,	NULL
Y.	NULL
Intracellular	NULL
signaling	NULL
by	NULL
hydrolysis	NULL
of	NULL
phospholipids	NULL
and	NULL
activation	NULL
of	NULL
protein	NULL
kinase	NULL
C.	NULL
Science	NULL
(	NULL
Washington	NULL
DC	NULL
)	NULL
,	NULL
258	NULL
:	NULL
607-614	NULL
,	NULL
1992	NULL
.	NULL

5	NULL
.	NULL

Christy	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
Lau	NULL
,	NULL
L.	NULL
R.	NULL
,	NULL
and	NULL
Nathans	NULL
,	NULL
D.	NULL
A	NULL
gene	NULL
activated	NULL
in	NULL
mouse	NULL
3T3	NULL
cells	NULL
by	NULL
serum	NULL
growth	NULL
factors	NULL
encodes	NULL
a	NULL
protein	NULL
with	NULL
``	NULL
zinc	NULL
finger	NULL
``	NULL
sequences	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
85	NULL
:	NULL
7857-7861	NULL
,	NULL
1988	NULL
.	NULL

6	NULL
.	NULL

Kharbanda	NULL
,	NULL
S.	NULL
,	NULL
Nakamura	NULL
,	NULL
T.	NULL
,	NULL
Stone	NULL
,	NULL
R.	NULL
,	NULL
Hass	NULL
,	NULL
R.	NULL
,	NULL
Bernstein	NULL
,	NULL
S.	NULL
,	NULL
Sukhatme	NULL
,	NULL
V.	NULL
,	NULL
and	NULL
Kufe	NULL
,	NULL
D.	NULL
Expression	NULL
of	NULL
the	NULL
EGR-1	NULL
and	NULL
EGR-2	NULL
zinc	NULL
finger	NULL
genes	NULL
during	NULL
induction	NULL
of	NULL
monocytic	NULL
differentiation	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

,	NULL
88	NULL
:	NULL
571-577	NULL
,	NULL
1991	NULL
.	NULL

7	NULL
.	NULL

Lemaire	NULL
,	NULL
P.	NULL
,	NULL
Revelant	NULL
,	NULL
O.	NULL
,	NULL
Bravo	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Charney	NULL
,	NULL
P.	NULL
Two	NULL
mouse	NULL
genes	NULL
encoding	NULL
potential	NULL
transcription	NULL
factors	NULL
with	NULL
identical	NULL
DNA-binding	NULL
domains	NULL
are	NULL
activated	NULL
by	NULL
growth	NULL
factors	NULL
in	NULL
cultured	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
85	NULL
:	NULL
4691-4695	NULL
,	NULL
1988	NULL
.	NULL

8	NULL
.	NULL

Lim	NULL
,	NULL
R.	NULL
W.	NULL
,	NULL
Varnum	NULL
,	NULL
B.	NULL
C.	NULL
,	NULL
and	NULL
Herschman	NULL
,	NULL
H.	NULL
R.	NULL
Cloning	NULL
of	NULL
tetra-decanoylphorbo	NULL
!	NULL

ester	NULL
induced	NULL
``	NULL
primary	NULL
response	NULL
``	NULL
sequences	NULL
and	NULL
their	NULL
expression	NULL
in	NULL
density-arrested	NULL
Swiss	NULL
3T3	NULL
cells	NULL
and	NULL
a	NULL
TPA	NULL
nonproliferative	NULL
variant	NULL
.	NULL

Oncogene	NULL
,	NULL
7	NULL
:	NULL
263-270	NULL
,	NULL
1987	NULL
.	NULL

9	NULL
.	NULL

Milbrandt	NULL
,	NULL
J	NULL
.	NULL

A	NULL
nerve	NULL
growth	NULL
factor-induced	NULL
gene	NULL
encodes	NULL
a	NULL
possible	NULL
transcriptional	NULL
regulatory	NULL
factor	NULL
.	NULL

Science	NULL
(	NULL
Washington	NULL
DC	NULL
)	NULL
,	NULL
238:797-799	NULL
,	NULL
1987	NULL
.	NULL

10	NULL
.	NULL

Sukhatme	NULL
,	NULL
V.	NULL
P.	NULL
,	NULL
Cao	NULL
,	NULL
X.	NULL
,	NULL
Chang	NULL
,	NULL
L.	NULL
C.	NULL
,	NULL
Tsai-Morris	NULL
,	NULL
C-H.	NULL
,	NULL
Stamenkovich	NULL
,	NULL
D.	NULL
,	NULL
Ferreira	NULL
,	NULL
P.	NULL
C.	NULL
P.	NULL
,	NULL
Cohen	NULL
,	NULL
D.	NULL
R.	NULL
,	NULL
Edwards	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
Shows	NULL
,	NULL
T.	NULL
B.	NULL
,	NULL
Curran	NULL
,	NULL
T.	NULL
,	NULL
Cell	NULL
Growth	NULL
&	NULL
Differentiation	NULL
LeBeau	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
and	NULL
Adamson	NULL
,	NULL
E.	NULL
D.	NULL
A	NULL
zinc	NULL
finger-encoding	NULL
gene	NULL
coregulated	NULL
with	NULL
c-fos	NULL
during	NULL
growth	NULL
and	NULL
differentiation	NULL
,	NULL
and	NULL
after	NULL
cellular	NULL
depolarization	NULL
.	NULL

Cell	NULL
,	NULL
53	NULL
:	NULL
37-43	NULL
,	NULL
1988	NULL
.	NULL

11	NULL
.	NULL

Bernstein	NULL
,	NULL
S.	NULL
H.	NULL
,	NULL
Kharbanda	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Sherman	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
Sukhatme	NULL
,	NULL
V.	NULL
P.	NULL
,	NULL
and	NULL
Kufe	NULL
,	NULL
D.	NULL
W.	NULL
Posttranscriptional	NULL
regulation	NULL
of	NULL
the	NULL
zinc	NULL
finger-encoding	NULL
EGR-1	NULL
gene	NULL
by	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
in	NULL
human	NULL
U-937	NULL
monocytic	NULL
leukemia	NULL
cells	NULL
:	NULL
involvement	NULL
of	NULL
a	NULL
pertussis	NULL
toxin-sensitive	NULL
G	NULL
protein	NULL
.	NULL

Cell	NULL
Growth	NULL
&	NULL
Differ	NULL
.	NULL

,	NULL
2	NULL
:	NULL
273-278	NULL
,	NULL
1991	NULL
.	NULL

12	NULL
.	NULL

Jingwen	NULL
,	NULL
L.	NULL
,	NULL
Lacy	NULL
,	NULL
J.	NULL
,	NULL
Sukhatme	NULL
,	NULL
V.	NULL
P.	NULL
,	NULL
and	NULL
Coleman	NULL
,	NULL
D.	NULL
L.	NULL
Granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
induces	NULL
transcriptional	NULL
activation	NULL
of	NULL
Egr-1	NULL
in	NULL
murine	NULL
peritoneal	NULL
macrophages	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
266	NULL
:	NULL
5229-5933	NULL
,	NULL
1991	NULL
.	NULL

13	NULL
.	NULL

Kharbanda	NULL
,	NULL
S.	NULL
,	NULL
Rubin	NULL
,	NULL
E.	NULL
,	NULL
Datta	NULL
,	NULL
R.	NULL
,	NULL
Hass	NULL
,	NULL
R.	NULL
,	NULL
Sukhatme	NULL
,	NULL
V.	NULL
,	NULL
and	NULL
Kufe	NULL
,	NULL
D.	NULL
Transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
early	NULL
growth	NULL
response	NULL
1	NULL
gene	NULL
in	NULL
human	NULL
myeloid	NULL
leukemia	NULL
cells	NULL
by	NULL
okadaic	NULL
acid	NULL
.	NULL

Cell	NULL
Growth	NULL
&	NULL
Differ	NULL
.	NULL

,	NULL
4	NULL
:	NULL
17-23	NULL
,	NULL
1993	NULL
.	NULL

14	NULL
.	NULL

Nguyen	NULL
,	NULL
H.	NULL
Q.	NULL
,	NULL
Hoffman-Liebermann	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
Liebermann	NULL
,	NULL
D.	NULL
A	NULL
.	NULL

The	NULL
zinc	NULL
finger	NULL
transcription	NULL
factor	NULL
Egr-1	NULL
is	NULL
essential	NULL
for	NULL
and	NULL
restricts	NULL
differentiation	NULL
along	NULL
the	NULL
macrophage	NULL
lineage	NULL
.	NULL

Cell	NULL
,	NULL
72	NULL
:	NULL
197-209	NULL
,	NULL
1993	NULL
.	NULL

15	NULL
.	NULL

Seyfert	NULL
,	NULL
V.	NULL
L.	NULL
,	NULL
Sukhatme	NULL
,	NULL
V.	NULL
P.	NULL
,	NULL
and	NULL
Munroe	NULL
,	NULL
J.	NULL
G.	NULL
Differential	NULL
expression	NULL
of	NULL
a	NULL
zinc	NULL
finger-encoding	NULL
gene	NULL
in	NULL
response	NULL
to	NULL
positive	NULL
versus	NULL
negative	NULL
signaling	NULL
through	NULL
receptor	NULL
immunoglobulin	NULL
in	NULL
murine	NULL
B	NULL
lymphocytes	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
9	NULL
:	NULL
2983-2088	NULL
,	NULL
1989	NULL
.	NULL

16	NULL
.	NULL

Sukhatme	NULL
,	NULL
V.	NULL
P.	NULL
,	NULL
Kartha	NULL
,	NULL
S.	NULL
,	NULL
Toback	NULL
,	NULL
F.	NULL
G.	NULL
,	NULL
Taub	NULL
,	NULL
R.	NULL
,	NULL
Hoover	NULL
,	NULL
R.	NULL
G.	NULL
,	NULL
and	NULL
Tsai-Morris	NULL
,	NULL
C-H.	NULL
A	NULL
novel	NULL
early	NULL
growth	NULL
response	NULL
gene	NULL
rapidly	NULL
induced	NULL
by	NULL
fibroblast	NULL
,	NULL
epithelial	NULL
cell	NULL
and	NULL
lymphocyte	NULL
mitogens	NULL
.	NULL

Oncogene	NULL
Res	NULL
.	NULL

,	NULL
1	NULL
:	NULL
343-355	NULL
,	NULL
1987	NULL
.	NULL

17	NULL
.	NULL

Banerjee	NULL
,	NULL
P.	NULL
,	NULL
Ahmad	NULL
,	NULL
M.	NULL
F.	NULL
,	NULL
Grove	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
Kozlosky	NULL
,	NULL
C.	NULL
,	NULL
Price	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
and	NULL
Avruch	NULL
,	NULL
J.	NULL
Molecular	NULL
structure	NULL
of	NULL
a	NULL
major	NULL
insulin/mitogen-activated	NULL
70-kDa	NULL
S6	NULL
protein	NULL
kinase	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
87	NULL
:	NULL
8550-8554	NULL
,	NULL
1990	NULL
.	NULL

18	NULL
.	NULL

Chen	NULL
,	NULL
R-H.	NULL
,	NULL
and	NULL
Blenis	NULL
,	NULL
J	NULL
.	NULL

Identification	NULL
of	NULL
Xenopus	NULL
S6	NULL
protein	NULL
kinase	NULL
homologs	NULL
(	NULL
pp90	NULL
``	NULL
**	NULL
)	NULL
in	NULL
somatic	NULL
cells	NULL
:	NULL
phosphorylation	NULL
and	NULL
activation	NULL
during	NULL
initiation	NULL
of	NULL
cell	NULL
proliferation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
10	NULL
:	NULL
3204-3215	NULL
,	NULL
1990	NULL
.	NULL

19	NULL
.	NULL

Kozma	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
Ferrari	NULL
,	NULL
S.	NULL
,	NULL
Bassand	NULL
,	NULL
P.	NULL
,	NULL
Siegmann	NULL
,	NULL
M.	NULL
,	NULL
Totty	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Thomas	NULL
,	NULL
G.	NULL
Cloning	NULL
of	NULL
the	NULL
mitogen-activated	NULL
S6	NULL
kinase	NULL
from	NULL
rat	NULL
liver	NULL
reveals	NULL
an	NULL
enzyme	NULL
of	NULL
the	NULL
second	NULL
messenger	NULL
subfamily	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
87	NULL
:	NULL
7365-7369	NULL
,	NULL
1990	NULL
.	NULL

20	NULL
.	NULL

Sweet	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
Alcorta	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
Jones	NULL
,	NULL
S.	NULL
W.	NULL
,	NULL
Erikson	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Erikson	NULL
,	NULL
R.	NULL
L.	NULL
Identification	NULL
of	NULL
mitogen-responsive	NULL
ribosomal	NULL
protein	NULL
S6	NULL
kinase	NULL
a	NULL
homolog	NULL
of	NULL
Xenopus	NULL
S6	NULL
kinase	NULL
II	NULL
,	NULL
in	NULL
chicken	NULL
embryo	NULL
fibroblasts	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
10	NULL
:	NULL
2413-2417	NULL
,	NULL
1990	NULL
.	NULL

21	NULL
.	NULL

Ballou	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
Luther	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Thomas	NULL
,	NULL
G.	NULL
MAP2	NULL
kinase	NULL
and	NULL
70k	NULL
$	NULL
6	NULL
kinase	NULL
lie	NULL
on	NULL
distinct	NULL
signalling	NULL
pathways	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

,	NULL
349	NULL
:	NULL
348-350	NULL
,	NULL
1990	NULL
.	NULL

22	NULL
.	NULL

Chen	NULL
,	NULL
R-H.	NULL
,	NULL
Chung	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Blenis	NULL
,	NULL
J	NULL
.	NULL

Regulation	NULL
of	NULL
pp9Orsk	NULL
phosphorylation	NULL
and	NULL
$	NULL
6	NULL
phosphotransferase	NULL
activity	NULL
in	NULL
Swiss	NULL
373	NULL
cells	NULL
by	NULL
growth	NULL
factor-	NULL
,	NULL
phorbol	NULL
ester-	NULL
and	NULL
cyclic	NULL
AMP-mediated	NULL
signal	NULL
transduction	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
11	NULL
:	NULL
1861-1867	NULL
,	NULL
1991	NULL
.	NULL

23	NULL
.	NULL

Chung	NULL
,	NULL
J.	NULL
,	NULL
Pelech	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Blenis	NULL
,	NULL
J.	NULL
Mitogen-activated	NULL
Swiss	NULL
mouse	NULL
3T3	NULL
RSK	NULL
kinase	NULL
I	NULL
and	NULL
II	NULL
are	NULL
related	NULL
to	NULL
pp44	NULL
``	NULL
``	NULL
``	NULL
*	NULL
from	NULL
sea	NULL
star	NULL
oocytes	NULL
and	NULL
participate	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
pp90	NULL
activity	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
88	NULL
:	NULL
4981-4985	NULL
,	NULL
1991	NULL
.	NULL

24	NULL
.	NULL

Sturgill	NULL
,	NULL
T.	NULL
W.	NULL
,	NULL
Ray	NULL
,	NULL
L.	NULL
B.	NULL
,	NULL
Erikson	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Maller	NULL
,	NULL
J.	NULL
L.	NULL
Insulin-stimulated	NULL
MAP-2	NULL
kinase	NULL
phosphorylates	NULL
and	NULL
activates	NULL
ribosomal	NULL
protein	NULL
S6	NULL
kinase	NULL
1	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

,	NULL
334	NULL
:	NULL
715-718	NULL
,	NULL
1988	NULL
.	NULL

25	NULL
.	NULL

Alvarez	NULL
,	NULL
E.	NULL
,	NULL
Northwood	NULL
,	NULL
1	NULL
.	NULL

C.	NULL
,	NULL
Gonzalez	NULL
,	NULL
F.	NULL
A.	NULL
,	NULL
Latour	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
Seth	NULL
,	NULL
A.	NULL
,	NULL
Abate	NULL
,	NULL
C.	NULL
,	NULL
Curran	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Davis	NULL
,	NULL
R.	NULL
J.	NULL
Pro-Leu-Ser/Thr-Pro	NULL
is	NULL
a	NULL
consensus	NULL
primary	NULL
sequence	NULL
for	NULL
substrate	NULL
protein	NULL
phosphorylation	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
266	NULL
:	NULL
15277-15285	NULL
,	NULL
1991	NULL
.	NULL

26	NULL
.	NULL

Pulverer	NULL
,	NULL
B.	NULL
J.	NULL
,	NULL
Kyriakis	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Avruch	NULL
,	NULL
J.	NULL
,	NULL
Nikolakaki	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Woodgett	NULL
,	NULL
J.	NULL
R.	NULL
Phosphorylation	NULL
of	NULL
c-Jun	NULL
mediated	NULL
by	NULL
MAP	NULL
kinases	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

,	NULL
353	NULL
:	NULL
670-674	NULL
,	NULL
1991	NULL
.	NULL

27	NULL
.	NULL

Chen	NULL
,	NULL
R-H.	NULL
,	NULL
Sarnecki	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Blenis	NULL
,	NULL
J	NULL
.	NULL

Nuclear	NULL
localization	NULL
and	NULL
regulation	NULL
of	NULL
erk-	NULL
and	NULL
rsk-encoded	NULL
protein	NULL
kinases	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
12:915-927	NULL
,	NULL
1992	NULL
.	NULL

28	NULL
.	NULL

Rivera	NULL
,	NULL
V.	NULL
M.	NULL
,	NULL
Miranti	NULL
,	NULL
C.	NULL
K.	NULL
,	NULL
Misra	NULL
,	NULL
R.	NULL
P.	NULL
,	NULL
Ginty	NULL
,	NULL
D.	NULL
D.	NULL
,	NULL
Chen	NULL
,	NULL
R-H.	NULL
,	NULL
Blenis	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Greenberg	NULL
,	NULL
M.	NULL
E.	NULL
A	NULL
growth	NULL
factor-induced	NULL
kinase	NULL
phosphorylates	NULL
the	NULL
serum	NULL
response	NULL
factor	NULL
at	NULL
a	NULL
site	NULL
that	NULL
regulates	NULL
its	NULL
DNA-binding	NULL
activity	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
13	NULL
:	NULL
6260-6273	NULL
,	NULL
1993	NULL
.	NULL

29	NULL
.	NULL

Hershey	NULL
,	NULL
J.	NULL
W.	NULL
B	NULL
.	NULL

Protein	NULL
phosphorylation	NULL
controls	NULL
translational	NULL
rates	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
264	NULL
:	NULL
20823-20826	NULL
,	NULL
1989	NULL
.	NULL

30	NULL
.	NULL

Ferrari	NULL
,	NULL
S.	NULL
,	NULL
Bannwarth	NULL
,	NULL
W.	NULL
,	NULL
Morley	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
Totty	NULL
,	NULL
N.	NULL
F.	NULL
,	NULL
and	NULL
Thomas	NULL
,	NULL
G.	NULL
Activation	NULL
of	NULL
p70°®®	NULL
is	NULL
associated	NULL
with	NULL
phosphorylation	NULL
of	NULL
four	NULL
clustered	NULL
sites	NULL
displaying	NULL
Ser/Thr-Pro	NULL
motifs	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
89	NULL
:	NULL
7282-7286	NULL
,	NULL
1992	NULL
.	NULL

31	NULL
.	NULL

Chung	NULL
,	NULL
J.	NULL
,	NULL
Kuo	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
,	NULL
and	NULL
Blenis	NULL
,	NULL
J.	NULL
Rapamycin-FKBP	NULL
specifically	NULL
blocks	NULL
growth-dependent	NULL
activation	NULL
of	NULL
and	NULL
signaling	NULL
by	NULL
the	NULL
70	NULL
kd	NULL
S6	NULL
kinase	NULL
.	NULL

Cell	NULL
,	NULL
69	NULL
:	NULL
1-20	NULL
,	NULL
1992	NULL
.	NULL

32	NULL
.	NULL

Kuo	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
Chung	NULL
,	NULL
J.	NULL
,	NULL
Florentino	NULL
,	NULL
D.	NULL
F.	NULL
,	NULL
Flanagan	NULL
,	NULL
W.	NULL
M.	NULL
,	NULL
Blenis	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
Rapamycin	NULL
selectively	NULL
inhibits	NULL
interleukin-2	NULL
activation	NULL
of	NULL
p70	NULL
S6	NULL
kinase	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

,	NULL
358	NULL
:	NULL
70-73	NULL
,	NULL
1992	NULL
.	NULL

33	NULL
.	NULL

Price	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Grove	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
Calvo	NULL
,	NULL
V.	NULL
,	NULL
Avruch	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Bierer	NULL
,	NULL
B.	NULL
E.	NULL
Rapamycin-induced	NULL
inhibition	NULL
of	NULL
the	NULL
70-kilodalton	NULL
$	NULL
6	NULL
protein	NULL
kinase	NULL
.	NULL

Science	NULL
(	NULL
Washington	NULL
DC	NULL
)	NULL
,	NULL
257	NULL
:	NULL
973-977	NULL
,	NULL
1992	NULL
.	NULL

34	NULL
.	NULL

Blenis	NULL
,	NULL
J.	NULL
,	NULL
Chung	NULL
,	NULL
J.	NULL
,	NULL
Erikson	NULL
,	NULL
E.	NULL
,	NULL
Alcorta	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
and	NULL
Erikson	NULL
,	NULL
R.	NULL
L.	NULL
Distinct	NULL
mechanisms	NULL
for	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
RSK	NULL
kinases/MAP2	NULL
kinase/pp90	NULL
``	NULL
*	NULL
and	NULL
pp70-56	NULL
kinase	NULL
signaling	NULL
systems	NULL
are	NULL
indicated	NULL
by	NULL
inhibition	NULL
of	NULL
protein	NULL
syn-thesis	NULL
.	NULL

Cell	NULL
Growth	NULL
&	NULL
Differ	NULL
.	NULL

,	NULL
2	NULL
:	NULL
279-285	NULL
,	NULL
1991	NULL
.	NULL

35	NULL
.	NULL

Chung	NULL
,	NULL
J.	NULL
,	NULL
Chen	NULL
,	NULL
R-H.	NULL
,	NULL
and	NULL
Blenis	NULL
,	NULL
J	NULL
.	NULL

Coordinate	NULL
regulation	NULL
of	NULL
pp90	NULL
``	NULL
**	NULL
and	NULL
a	NULL
distinct	NULL
protein-serine/threonine	NULL
kinase	NULL
activity	NULL
that	NULL
phosphorylates	NULL
recom-binant	NULL
pp90	NULL
``	NULL
®	NULL
in	NULL
vitro	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
17	NULL
:	NULL
1868-1874	NULL
,	NULL
1991	NULL
.	NULL

36	NULL
.	NULL

Hass	NULL
,	NULL
R.	NULL
,	NULL
Hirano	NULL
,	NULL
M.	NULL
,	NULL
Kharbanda	NULL
,	NULL
S.	NULL
,	NULL
Rubin	NULL
,	NULL
E.	NULL
,	NULL
Meinhardt	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Kufe	NULL
,	NULL
D.	NULL
Resistance	NULL
to	NULL
phorbol	NULL
ester-induced	NULL
differentiation	NULL
of	NULL
a	NULL
U-937	NULL
myeloid	NULL
leukemia	NULL
cell	NULL
variant	NULL
with	NULL
a	NULL
signaling	NULL
defect	NULL
upstream	NULL
to	NULL
Raf-1	NULL
kinase	NULL
.	NULL

Cell	NULL
Growth	NULL
&	NULL
Differ	NULL
.	NULL

,	NULL
4	NULL
:	NULL
657-663	NULL
,	NULL
1993	NULL
.	NULL

37	NULL
.	NULL

Bialojan	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Takai	NULL
,	NULL
A.	NULL
Inhibitory	NULL
effects	NULL
of	NULL
a	NULL
marine	NULL
sponge	NULL
toxin	NULL
,	NULL
okadaic	NULL
acid	NULL
,	NULL
on	NULL
protein	NULL
phosphatases	NULL
:	NULL
specificity	NULL
and	NULL
kinetics	NULL
.	NULL

Biochem	NULL
.	NULL

J.	NULL
,	NULL
256	NULL
:	NULL
283-290	NULL
,	NULL
1988	NULL
.	NULL

38	NULL
.	NULL

Cohen	NULL
,	NULL
P.	NULL
,	NULL
Holmes	NULL
,	NULL
C.	NULL
F.	NULL
B.	NULL
,	NULL
and	NULL
Tsukitani	NULL
,	NULL
Y.	NULL
Okadaic	NULL
acid	NULL
:	NULL
a	NULL
new	NULL
probe	NULL
for	NULL
the	NULL
study	NULL
of	NULL
cellular	NULL
regulation	NULL
.	NULL

Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

,	NULL
15	NULL
:	NULL
98-102	NULL
,	NULL
1990	NULL
.	NULL

39	NULL
.	NULL

Haystead	NULL
,	NULL
T.	NULL
A.	NULL
J.	NULL
,	NULL
Sim	NULL
,	NULL
A.	NULL
T.	NULL
R.	NULL
,	NULL
Carling	NULL
,	NULL
D.	NULL
,	NULL
Honnor	NULL
,	NULL
R.	NULL
C.	NULL
,	NULL
Tsukitani	NULL
,	NULL
Y.	NULL
,	NULL
Cohen	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Hardie	NULL
,	NULL
D.	NULL
G.	NULL
Effects	NULL
of	NULL
the	NULL
tumor	NULL
promoter	NULL
okadaic	NULL
acid	NULL
on	NULL
intracellular	NULL
protein	NULL
phosphorylation	NULL
and	NULL
metabolism	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

,	NULL
337	NULL
:	NULL
78-81	NULL
,	NULL
1989	NULL
.	NULL

40	NULL
.	NULL

Kharbanda	NULL
,	NULL
S.	NULL
,	NULL
Datta	NULL
,	NULL
R.	NULL
,	NULL
Rubin	NULL
,	NULL
E.	NULL
,	NULL
Nakamura	NULL
,	NULL
T.	NULL
,	NULL
Hass	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Kufe	NULL
,	NULL
D.	NULL
Regulation	NULL
of	NULL
c-jun	NULL
expression	NULL
during	NULL
induction	NULL
of	NULL
monocytic	NULL
differentiation	NULL
by	NULL
okadaic	NULL
acid	NULL
.	NULL

Cell	NULL
Growth	NULL
&	NULL
Differ	NULL
.	NULL

,	NULL
3	NULL
:	NULL
391-399	NULL
,	NULL
1992	NULL
.	NULL

41	NULL
.	NULL

Datta	NULL
,	NULL
R.	NULL
,	NULL
Hallahan	NULL
,	NULL
D.	NULL
,	NULL
Kharbanda	NULL
,	NULL
S.	NULL
,	NULL
Rubin	NULL
,	NULL
E.	NULL
,	NULL
Sherman	NULL
,	NULL
M.	NULL
,	NULL
Huberman	NULL
,	NULL
E.	NULL
,	NULL
Weichselbaum	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Kufe	NULL
,	NULL
D.	NULL
Involvement	NULL
of	NULL
reactive	NULL
oxygen	NULL
intermediates	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
c-jun	NULL
gene	NULL
transcription	NULL
by	NULL
ionizing	NULL
radia-tion	NULL
.	NULL

Biochemistry	NULL
,	NULL
37	NULL
:	NULL
8300-8306	NULL
,	NULL
1992	NULL
.	NULL

42	NULL
.	NULL

Nishikawa	NULL
,	NULL
M.	NULL
,	NULL
Komada	NULL
,	NULL
F.	NULL
,	NULL
Uemura	NULL
,	NULL
Y.	NULL
,	NULL
Hidaka	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Hirakawa	NULL
,	NULL
S.	NULL
Decreased	NULL
expression	NULL
of	NULL
type	NULL
II	NULL
protein	NULL
kinase	NULL
C	NULL
in	NULL
HL-60	NULL
variant	NULL
cells	NULL
resistant	NULL
to	NULL
induction	NULL
of	NULL
cell	NULL
differentiation	NULL
by	NULL
phorbol	NULL
ester	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

,	NULL
50	NULL
:	NULL
621-626	NULL
,	NULL
1990	NULL
.	NULL

43	NULL
.	NULL

Ward	NULL
,	NULL
G.	NULL
E.	NULL
,	NULL
and	NULL
Kirshner	NULL
,	NULL
M.	NULL
W.	NULL
Identification	NULL
of	NULL
cell	NULL
cycle-regulated	NULL
phosphorylation	NULL
sites	NULL
on	NULL
nuclear	NULL
lamin	NULL
C.	NULL
Cell	NULL
,	NULL
67	NULL
:	NULL
561-577	NULL
,	NULL
1990	NULL
.	NULL

44	NULL
.	NULL

Erickson	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Maller	NULL
,	NULL
J.	NULL
L.	NULL
Substrate	NULL
specificity	NULL
of	NULL
ribosomal	NULL
protein	NULL
S6	NULL
kinase	NULL
I1	NULL
from	NULL
Xenopus	NULL
eggs	NULL
.	NULL

Second	NULL
Messenger	NULL
Phosphoprot	NULL
.	NULL

,	NULL
2	NULL
:	NULL
135-143	NULL
,	NULL
1988	NULL
.	NULL

45	NULL
.	NULL

Ofir	NULL
,	NULL
R.	NULL
,	NULL
Dwarki	NULL
,	NULL
V.	NULL
J.	NULL
,	NULL
Rashid	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Verma	NULL
,	NULL
I.	NULL
M.	NULL
Phosphorylation	NULL
of	NULL
the	NULL
C	NULL
terminus	NULL
of	NULL
Fos	NULL
protein	NULL
is	NULL
required	NULL
for	NULL
transcriptional	NULL
transrepression	NULL
of	NULL
the	NULL
c-fos	NULL
promoter	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

,	NULL
348	NULL
:	NULL
80-82	NULL
,	NULL
1990	NULL
.	NULL

46	NULL
.	NULL

Gius	NULL
,	NULL
D.	NULL
,	NULL
Cao	NULL
,	NULL
X.	NULL
,	NULL
Rauscher	NULL
,	NULL
F.	NULL
J.	NULL
,	NULL
III	NULL
,	NULL
Cohen	NULL
,	NULL
D.	NULL
R.	NULL
,	NULL
Curran	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Sukhatme	NULL
,	NULL
V.	NULL
Transcriptional	NULL
activation	NULL
and	NULL
repression	NULL
by	NULL
fos	NULL
are	NULL
independent	NULL
functions	NULL
:	NULL
the	NULL
C	NULL
terminus	NULL
represses	NULL
immediate-early	NULL
gene	NULL
expression	NULL
via	NULL
CArG	NULL
elements	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
10	NULL
:	NULL
4243-4255	NULL
,	NULL
1990	NULL
.	NULL

47	NULL
.	NULL

Prywes	NULL
,	NULL
R.	NULL
,	NULL
Dutta	NULL
,	NULL
A.	NULL
,	NULL
Cromlish	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Roeder	NULL
,	NULL
R.	NULL
Phosphorylation	NULL
of	NULL
serum	NULL
response	NULL
factor	NULL
,	NULL
a	NULL
factor	NULL
that	NULL
binds	NULL
to	NULL
the	NULL
serum	NULL
response	NULL
element	NULL
of	NULL
the	NULL
c-fos	NULL
enhancer	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
85	NULL
:	NULL
7206-7210	NULL
,	NULL
1988	NULL
.	NULL

48	NULL
.	NULL

Treisman	NULL
,	NULL
R.	NULL
Identification	NULL
of	NULL
a	NULL
protein-binding	NULL
site	NULL
that	NULL
mediates	NULL
transcriptional	NULL
response	NULL
of	NULL
the	NULL
c-fos	NULL
gene	NULL
to	NULL
serum	NULL
factors	NULL
.	NULL

Cell	NULL
,	NULL
46	NULL
:	NULL
567-574	NULL
,	NULL
1986	NULL
.	NULL

49	NULL
.	NULL

Gille	NULL
,	NULL
H.	NULL
,	NULL
Sharrocks	NULL
,	NULL
A.	NULL
D.	NULL
,	NULL
and	NULL
Shaw	NULL
,	NULL
P.	NULL
E.	NULL
Phosphorylation	NULL
of	NULL
transcription	NULL
factor	NULL
p62	NULL
``	NULL
by	NULL
MAP	NULL
kinase	NULL
stimulates	NULL
ternary	NULL
complex	NULL
formation	NULL
at	NULL
c-fos	NULL
promoter	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

,	NULL
358	NULL
:	NULL
414-417	NULL
,	NULL
1992	NULL
.	NULL

50	NULL
.	NULL

Sundstrom	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Nilsson	NULL
,	NULL
K.	NULL
Establishment	NULL
and	NULL
characterization	NULL
of	NULL
a	NULL
human	NULL
histiocytic	NULL
lymphoma	NULL
cell	NULL
line	NULL
(	NULL
U-937	NULL
)	NULL
.	NULL

Int	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
,	NULL
17	NULL
:	NULL
565-577	NULL
,	NULL
1976	NULL
.	NULL

51	NULL
.	NULL

Chirgwin	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Przybyla	NULL
,	NULL
A.	NULL
E.	NULL
,	NULL
MacDonald	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
and	NULL
Rutter	NULL
,	NULL
W.	NULL
J	NULL
.	NULL

Isolation	NULL
of	NULL
biologically	NULL
active	NULL
ribonucleic	NULL
acid	NULL
from	NULL
sources	NULL
enriched	NULL
in	NULL
ri-bonuclease	NULL
.	NULL

Biochemistry	NULL
,	NULL
18	NULL
:	NULL
5294-5299	NULL
,	NULL
1979	NULL
.	NULL

52	NULL
.	NULL

Cleveland	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
Lopata	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
MacDonald	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
Rutter	NULL
,	NULL
W.	NULL
J.	NULL
,	NULL
and	NULL
Kirschner	NULL
,	NULL
M.	NULL
W.	NULL
Number	NULL
and	NULL
evolutionary	NULL
conservation	NULL
of	NULL
a-	NULL
and	NULL
B-tubulin	NULL
and	NULL
cytoplasmic	NULL
B-	NULL
and	NULL
y-actin	NULL
genes	NULL
using	NULL
specific	NULL
cloned	NULL
cDNA	NULL
probes	NULL
.	NULL

Cell	NULL
,	NULL
20	NULL
:	NULL
95-105	NULL
,	NULL
1980	NULL
.	NULL

53	NULL
.	NULL

Grossched	NULL
!	NULL

,	NULL
R.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
Cell-type	NULL
specificity	NULL
of	NULL
immunoglobin	NULL
gene	NULL
expression	NULL
is	NULL
regulated	NULL
by	NULL
at	NULL
least	NULL
three	NULL
DNA	NULL
sequence	NULL
elements	NULL
.	NULL

Cell	NULL
,	NULL
41	NULL
:	NULL
885-897	NULL
,	NULL
1985	NULL
.	NULL

265	NULL

